<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma - Kirkland, SW - 2018 | Cochrane Library</title> <meta content="Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma - Kirkland, SW - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012629.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma - Kirkland, SW - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012629.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012629.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma" name="citation_title"/> <meta content="Scott W Kirkland" name="citation_author"/> <meta content="University of Alberta" name="citation_author_institution"/> <meta content="kirkland@ualberta.ca" name="citation_author_email"/> <meta content="Elfriede Cross" name="citation_author"/> <meta content="University of Alberta" name="citation_author_institution"/> <meta content="Sandra Campbell" name="citation_author"/> <meta content="University of Alberta" name="citation_author_institution"/> <meta content="Cristina Villa‐Roel" name="citation_author"/> <meta content="University of Alberta" name="citation_author_institution"/> <meta content="Brian H Rowe" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD012629.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/06/02" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012629.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012629.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012629.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Secondary Prevention; Acute Disease; Administration, Oral; Adrenal Cortex Hormones [*administration &amp; dosage]; Anti‐Asthmatic Agents [*administration &amp; dosage]; Asthma [drug therapy, *prevention &amp; control]; Betamethasone [administration &amp; dosage]; Dexamethasone [administration &amp; dosage]; Emergency Service, Hospital; Injections, Intramuscular; Methylprednisolone [administration &amp; dosage]; Patient Discharge; Prednisolone [administration &amp; dosage]; Prednisone [administration &amp; dosage]; Randomized Controlled Trials as Topic; Recurrence; Triamcinolone [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012629.pub2&amp;doi=10.1002/14651858.CD012629.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="JmNqPX1V";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012629\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012629\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ru","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012629.pub2",title:"Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma",firstPublishedDate:"Jun 2, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=JmNqPX1V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012629.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012629.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012629.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012629.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012629.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012629.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012629.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012629.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012629.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012629.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>12390 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012629.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-sec-0097"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-sec-0061"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-sec-0091"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/appendices#CD012629-sec-0102"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/table_n/CD012629StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/table_n/CD012629StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information#CD012629-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Scott W Kirkland</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information#CD012629-cr-0003">Elfriede Cross</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information#CD012629-cr-0004">Sandra Campbell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information#CD012629-cr-0005">Cristina Villa‐Roel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information#CD012629-cr-0006">Brian H Rowe</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information/en#CD012629-sec-0119">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 02 June 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012629.pub2">https://doi.org/10.1002/14651858.CD012629.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012629-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012629-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012629-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012629-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012629-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012629-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012629-abs-0001" lang="en"> <section id="CD012629-sec-0001"> <h3 class="title" id="CD012629-sec-0001">Background</h3> <p>Acute asthma is a common cause of presentations to acute care centres, such as the emergency department (ED), and while the majority of patients can be discharged, relapse requiring additional medical care is common. Systemic corticosteroids are a major part in the treatment of moderate to severe acute asthma; however, there is no clear evidence regarding the most effective route of administration for improving outcomes in patients discharged from acute care. </p> </section> <section id="CD012629-sec-0002"> <h3 class="title" id="CD012629-sec-0002">Objectives</h3> <p>To examine the effectiveness and safety of a single dose of intramuscular (IM) corticosteroids provided prior to discharge compared to a short course of oral corticosteroids in the treatment of acute asthma patients discharged from an ED or equivalent acute care setting. </p> </section> <section id="CD012629-sec-0003"> <h3 class="title" id="CD012629-sec-0003">Search methods</h3> <p>The Cochrane Airways Group conducted searches of the Cochrane Airways Group Register of Trials, most recently on 14 March 2018. In addition in April 2017 we completed an extensive search of nine electronic databases including Medline, Embase, EBM ALL, Global Health, International Pharmaceutical Abstracts, CINAHL, SCOPUS, Proquest Dissertations and Theses Global, and LILACS. Furthermore, we searched the grey literature to identify any additional studies. </p> </section> <section id="CD012629-sec-0004"> <h3 class="title" id="CD012629-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials or controlled clinical trials if they compared the effectiveness of intramuscular (IM) versus oral corticosteroids to treat paediatric or adult patients presenting with acute asthma to an ED or equivalent acute care setting. Two independent reviewers assessed study eligibility and study quality. We resolved disagreements via a third party and assessed risk of bias using the Cochrane 'Risk of bias' tool. We assessed the quality of the evidence using GRADE. </p> </section> <section id="CD012629-sec-0005"> <h3 class="title" id="CD012629-sec-0005">Data collection and analysis</h3> <p>For dichotomous outcomes, we calculated individual and pooled statistics as risk ratios (RRs) with 95% confidence intervals (CIs) using a random‐effects model. We reported continuous outcomes using mean difference (MD) or standardised mean difference (SMD) with 95% CIs using a random‐effects model. We reported heterogeneity using I² and Cochran Q statistics. We used standard procedures recommended by Cochrane. </p> </section> <section id="CD012629-sec-0006"> <h3 class="title" id="CD012629-sec-0006">Main results</h3> <p>Nine studies involving 804 participants (IM = 402 participants; oral = 402 participants) met our review inclusion criteria. Four studies enrolled children (n = 245 participants), while five studies enrolled adults (n = 559 participants). All of the studies recruited participants presenting to an ED, except one study which recruited participants attending a primary care clinic. All of the paediatric studies compared intramuscular (IM) dexamethasone to oral prednisone/prednisolone. In the adult studies, the IM corticosteroid provided ranged from methylprednisolone, betamethasone, dexamethasone, or triamcinolone, while the regimen of oral corticosteroids provided consisted of prednisone, methylprednisolone, or dexamethasone. Only five studies were placebo controlled. For the purposes of this review, we did not take corticosteroid dose equivalency into account in the analysis. The most common co‐intervention provided to participants during the acute care visit included short‐acting beta₂‐agonists (SABA), methylxanthines, and ipratropium bromide. In some instances, some studies reported providing some participants with supplemental oral or IV corticosteroids during their stay in the ED. Co‐interventions provided to participants at discharge consisted primarily of SABA, methylxanthine, long‐acting beta₂‐agonists (LABA), and ipratropium bromide. The risk of bias of the included studies ranged from unclear to high across various domains. The primary outcome of interest was relapse to additional care defined as an unscheduled visit to a health practitioner for worsening asthma symptoms, or requiring subsequent treatment with corticosteroids which may have occurred at any time point after discharge from the ED. </p> <p>We found intramuscular and oral corticosteroids to be similarly effective in reducing the risk for relapse (RR 0.94, 95% CI 0.72 to 1.24; 9 studies, 804 participants; I² = 0%; low‐quality evidence). We found no subgroup differences in relapse rates between paediatric and adult participants (P = 0.71), relapse occurring within or after 10 days post‐discharge (P = 0.22), or participants with mild/moderate or severe exacerbations (P = 0.35). While we found no statistical difference between participants receiving IM versus oral corticosteroids regarding the risk for adverse events (RR 0.83, 95% CI 0.64 to 1.07; 5 studies, 404 participants; I² = 0%; moderate‐quality evidence), an estimated 50 fewer patients per 1000 receiving IM corticosteroids reported experiencing adverse events (95% from 106 fewer to 21 more). We found inconsistent reporting of specific adverse events across the studies. There were no differences in the frequency of specific adverse events including nausea and vomiting, pain, swelling, redness, insomnia, or personality changes. We did not seek additional adverse events data. </p> <p>Participants receiving IM corticosteroids or oral corticosteroids both reported decreases in peak expiratory flow (MD −7.78 L/min, 95% CI −38.83 L/min to 23.28 L/min; 4 studies, 272 participants; I² = 33%; moderate‐quality evidence), similar symptom persistence (RR 0.41, 95% CI 0.14 to 1.20; 3 studies, 80 participants; I² = 44%; low‐quality evidence), and 24‐hour beta‐agonist use (RR 0.54, 95% CI 0.21 to 1.37; 2 studies, 48 participants; I² = 0%; low‐quality evidence). </p> </section> <section id="CD012629-sec-0007"> <h3 class="title" id="CD012629-sec-0007">Authors' conclusions</h3> <p>There is insufficient evidence to identify whether IM corticosteroids are more effective in reducing relapse compared to oral corticosteroids among children or adults discharged from an ED or equivalent acute care setting for acute asthma. While we found no statistical differences, patients receiving IM corticosteroids reported fewer adverse events. Additional studies comparing the effectiveness of IM versus oral corticosteroids could provide further evidence clarity. Furthermore, there is a need for studies comparing different IM corticosteroids (e.g. IM dexamethasone versus IM methylprednisone) and different oral corticosteroids (e.g. oral dexamethasone versus oral prednisone), with consideration for dosing and pharmacokinetic properties, to better identify the optimal IM or oral corticosteroid regimens to improve patient outcomes. Other factors, such as patient preference and potential issues with adherence, may dictate practitioner prescribing. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012629-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012629-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012629-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012629-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012629-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012629-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012629-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012629-abs-0009">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012629-abs-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012629-abs-0008">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012629-abs-0005" lang="en"> <h3>Intramuscular versus oral corticosteroids for acute asthma</h3> <p><b>Review question</b> </p> <p>We examined the effectiveness of an injection of corticosteroids compared to corticosteroids taken by mouth to improve outcomes among patients who presented to an emergency department or similar acute care setting with acute asthma. </p> <p><b>Background</b> </p> <p>Asthma attacks result from airway passages to the lungs becoming constricted due to inflammation, resulting in wheezing, coughing and difficulty breathing. People experiencing asthma attacks often go to emergency departments. Corticosteroids, which are powerful anti‐inflammatory agents, are the treatment cornerstone of asthma exacerbations, and have been shown to be effective in improving lung function and reducing hospitalisations in patients with asthma. At discharge, patients are commonly provided with corticosteroids to reduce the chance of returning to the emergency department due to worsening asthma symptoms. Corticosteroids may be provided via a single injection under the skin into the muscle ('intramuscular') or as tablets to take home, and it is currently unclear which regimen of corticosteroids is more effective at improving outcomes for patients following discharge from the emergency department. </p> <p><b>Search date</b> </p> <p>We conducted our most recent search in March 2018.</p> <p><b>Study characteristics</b> </p> <p>We included nine studies that compared the effectiveness of an intramuscular injection compared to corticosteroid tablets in patients presenting to an ED or similar acute care setting with acute asthma. The studies enrolled a total of 804 paediatric and adult participants. Most studies investigated the injectable corticosteroids dexamethasone or methylprednisolone compared to the corticosteroid tablets prednisone or methylprednisolone. </p> <p><b>Study funding sources</b> </p> <p>Most studies did not report sources of funding (5 studies). Two studies received funding from general health research grants. One study was funded by a pharmaceutical company (Pfizer); however, reported that the company was not involved in any aspect of the study or manuscript preparation. One study reported being unfunded. </p> <p><b>Key results</b> </p> <p>Intramuscular injections of corticosteroids appear to be as effective as corticosteroids tablets in preventing relapse. We did not find any differences in the risk of relapse between participants receiving intramuscular injections and corticosteroid tablets. Although not all studies reported adverse effects in their study groups, we found no differences between participants receiving intramuscular injections and corticosteroid tablets. At follow‐up, we found no differences in pulmonary function tests between participants who had received an intramuscular injection or corticosteroid tablets. In the studies that reported symptom scores and duration, we did not identify any differences between participants receiving corticosteroids by injection or by tablets. </p> <p><b>Quality of the evidence</b> </p> <p>The quality of the evidence regarding the effectiveness of intramuscular injections of corticosteroids in improving health outcomes ranged from low to moderate. We had only moderate confidence about the estimated effects of intramuscular steroids on hospital admissions, improvement in respiratory function and relapse because of the risk of bias among included studies. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012629-sec-0097" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012629-sec-0097">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012629-sec-0165">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012629-sec-0097"></div> <h3 class="title" id="CD012629-sec-0098">Implications for practice</h3> <section id="CD012629-sec-0098"> <p>For adults and children who have presented to the ED or equivalent acute care settings and who are suitable for discharge, a single dose of IM corticosteroids or a short dose of oral corticosteroids are both effective treatments to mitigate relapse events. We noted no differences with regards to pulmonary function, symptom persistence, or beta‐agonist use following treatment with either IM or oral corticosteroids. This review did not control for corticosteroid equivalency in the analysis; however, both arms used a moderate to high dose of intermediate‐duration agents. The review is also unable to reach conclusions regarding specific IM or oral corticosteroid treatments based on dosing or pharmacokinetic properties. </p> <p>There is some evidence to suggest IM corticosteroids may decrease the risk of adverse events by as much as 36%, compared to a 7% potential increase; however, IM delivery is painful and can cause inflammation or infection (or both) at the site of injection. </p> </section> <h3 class="title" id="CD012629-sec-0099">Implications for research</h3> <section id="CD012629-sec-0099"> <p>Additional comparative effectiveness studies of IM versus oral corticosteroids to improve patient outcomes are needed to better inform clinicians and patients about how best to optimise patient care. In particular, we recommend additional studies enrolling school‐aged children to better understand the effectiveness of IM versus oral corticosteroids in this age group. </p> <p>Additional comparative effectiveness studies using different IM corticosteroids (e.g. IM dexamethasone versus IM methylprednisone) and different oral corticosteroids (e.g. oral dexamethasone versus oral prednisone), with consideration for dosing and pharmacokinetic properties, are needed to explore the optimal IM or oral corticosteroid regimens to improve patient outcomes. </p> <p>We strongly recommend comprehensive and standardized outcome reporting including clearly defined criteria and adjudication of health services outcomes (e.g. relapses resulting in primary care or ED visits, hospitalisation, death), side effects, pulmonary function, and symptom prevalence in future studies. </p> <p>Compliance with the provided oral corticosteroid regimens was infrequently documented across the studies, and compliance, or lack thereof, could have impacted the results of this review. It is important that future comparative studies document compliance with oral corticosteroid regimens. </p> <p>Future research needs to consider and address potential sources of bias, including randomisation, concealment of allocation, blinded outcome assessment, placebo‐controlled, avoidance of selective outcome reporting, and complete documentation of follow‐up. </p> <p>Future research needs to better document the occurrence of adverse events associated with IM and oral corticosteroids, in particular adverse events associated with IM corticosteroids, which have been reported less extensively than those associated with oral corticosteroids, and range from pain, redness and swelling to rarer adverse events including avascular necrosis and hypothalamic/pituitary axis suppression. </p> <p>Future research needs to examine the effects of repeat treatments of IM or oral corticosteroids among paediatric or adult patients with frequent exacerbations. </p> <p>Given the importance of ICS agents in the chronic treatment of asthma, either alone or in combination with other agents, it is important that future research clearly documents the co‐interventions (e.g. ICS, ICS/LABA, monoclonal antibodies, etc.) provided to patients either in the ED, or at discharge, so that researchers may better understand the impact of these co‐interventions on the efficacy of IM or oral corticosteroids' reports on the pre‐ED and post‐ED use of all other anti‐inflammatory treatments (e.g. ICS, ICS/LABA, monoclonal antibodies, etc.). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012629-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012629-sec-0029"></div> <div class="table" id="CD012629-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Intramuscular corticosteroids compared to Oral corticosteroids for acute asthma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Intramuscular corticosteroids compared to Oral corticosteroids for acute asthma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with acute asthma<br/> <b>Settings:</b> Acute care settings<br/> <b>Intervention:</b> Intramuscular corticosteroids<br/> <b>Comparison:</b> Oral corticosteroids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Oral corticosteroids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Intramuscular corticosteroids</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relapse</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>201 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>12 fewer per 1000</b><br/> (from 56 fewer to 48 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b> <br/> (0.72 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>804<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relapse within 10 days post</b> ‐<b>discharge</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>154 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>40 fewer per 1000</b> </p> <p>(from 75 fewer to 11 more)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.74</b> <br/> (0.51 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>742<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relapse occurring after 10 days post</b> ‐<b>discharge</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>245 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>2 fewer per 1000</b><br/> (from 64 fewer to 81 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.99</b> <br/> (0.74 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>556<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>294 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>50 fewer per 1000</b><br/> (from 106 fewer to 21 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b> <br/> (0.64 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>404<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pulmonary function: Peak expiratory flow</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pulmonary function: peak expiratory flow ranged across control groups from<br/> <b>304 to 419 litres/min</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pulmonary function: peak expiratory flow in the intervention groups was<br/> <b>7.78 liters/min lower</b><br/> (38.83 lower to 23.28 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>272<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptom persistence</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>537 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>317 fewer per 1000</b><br/> (from 461 fewer to 107 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.41</b> <br/> (0.14 to 1.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>24</b> ‐<b>hour beta agonist use</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>375 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>172 fewer per 1000</b><br/> (from 296 fewer to 139 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.54</b> <br/> (0.21 to 1.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded 1 level for risk of bias. Majority of studies received an unclear risk of bias for random sequence generation and selective outcome reporting<br/> <sup>2</sup> Downgraded 1 level for imprecision including wide confidence intervals (including both benefit, harm, and no effect)<br/> <sup>3</sup> Downgraded 1 level for Imprecision including wide confidence intervals (including both benefit, harm, and no effect) and few events </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012629-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012629-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012629-sec-0128">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD012629-sec-0030"></div> <section id="CD012629-sec-0031"> <h3 class="title" id="CD012629-sec-0031">Description of the condition</h3> <p>Asthma is a chronic inflammatory disease of the airways of the lungs that affects both children and adults. It is estimated that 300 million people worldwide have asthma (<a href="./references#CD012629-bbs2-0024" title="CroisantS . Epidemiology of asthma: prevalence and burden of disease. Advances in Experimental Medicine and Biology2014;795:17‐29. [DOI: 10.1007/978‐1‐4614‐8603‐9_2] ">Croisant 2014</a>). In the United States, the prevalence of asthma has increased from 7.3% to 8.2% from 2001 to 2009 (<a href="./references#CD012629-bbs2-0024" title="CroisantS . Epidemiology of asthma: prevalence and burden of disease. Advances in Experimental Medicine and Biology2014;795:17‐29. [DOI: 10.1007/978‐1‐4614‐8603‐9_2] ">Croisant 2014</a>). Acute asthma, characterised by worsening cough, wheezing, shortness of breath, or chest tightness, is a common cause of presentation to the hospital emergency department (ED) or similar acute care settings. Most patients with acute asthma presenting to the ED can be safely managed with interventions including systemic corticosteroids, anticholinergics, or beta₂‐agonists, and discharged home (<a href="./references#CD012629-bbs2-0041" title="RoweBH , VoaklanderDC , WangD , SenthilselvanA , KlassenTP , MarrieTJ , et al. Asthma presentations by adults to emergency departments in Alberta, Canada: a large population‐based study. Chest2009;135(1):57‐65. [DOI: 10.1378/chest.07‐3041] ">Rowe 2009</a>). However, approximately 10% to 18% (<a href="./references#CD012629-bbs2-0027" title="EmermanCL , WoodruffPG , CydulkaRK , GibbsMA , PollackCVJr , CamargoCAJr . Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. MARC investigators. Multicenter Asthma Research Collaboration. Chest1999;115(4):919‐27. [PUBMED: 10208187] ">Emerman 1999</a>; <a href="./references#CD012629-bbs2-0028" title="EmermanCL , CydulkaRK , CrainEF , RoweBH , RadiosMS , CamargoCAJr , et al. Prospective multicenter study of relapse after treatment for acute asthma among children presenting to the emergency department. Journal of Pediatrics2001;138(3):318‐24. [DOI: 10.1067/mpd.2001.111320] ">Emerman 2001</a>; <a href="./references#CD012629-bbs2-0042" title="RoweBH , Villa‐RoelC , MajumdarSR , Abu‐LabanRB , AaronSD , StiellIG , et al. Rates and correlates of relapse following ED discharge for acute asthma: a Canadian 20‐site prospective cohort study. Chest2015;147(1):140‐9. [DOI: 10.1378/chest.14‐0843] ">Rowe 2015</a>; <a href="./references#CD012629-bbs2-0044" title="TopalE , GücenmezOA , HarmanciK , ArgaM , DerinozO , TurktasI . Potential predictors of relapse after treatment of asthma exacerbations in children. Annals of Allergy, Asthma and Immunology2014;112(4):361‐4. [DOI: 10.1016/j.anai.2014.01.025] ">Topal 2014</a>), and up to 31% (<a href="./references#CD012629-bbs2-0025" title="DucharmeFM , KramerMS . Relapse following emergency treatment for acute asthma: can it be predicted or prevented?. Journal of Clinical Epidemiology1993;46(12):1395‐402. [PUBMED: 8263566] ">Ducharme 1993</a>), of patients will relapse and return to the ED or other acute care settings with acute exacerbations of asthma within the following four weeks. In the US, it is estimated that the economic cost of asthma in 2007 was approximately USD 56 billion due to medical costs and missed work and school days (<a href="./references#CD012629-bbs2-0023" title="CDC . Asthma in the U.S. CDC Vital Signs. www.cdc.gov/vitalsigns/asthma.May 2011. ">CDC 2011</a>). Identifying effective treatment options to help patients manage their symptoms after discharge from acute care and reducing the proportion of patients who relapse are important management issues designed to improve health outcomes for patients with asthma. </p> </section> <section id="CD012629-sec-0032"> <h3 class="title" id="CD012629-sec-0032">Description of the intervention</h3> <p>Systemic corticosteroids are potent general anti‐inflammatory agents for the treatment of asthma (<a href="./references#CD012629-bbs2-0021" title="AlangariAA . Corticosteroids in the treatment of acute asthma. Annals of Thoracic Medicine2014;9(4):187‐92. [10.4103/1817‐1737.140120] ">Alangari 2014</a>). When given in the ED, systemic corticosteroids can reduce hospitalisations and improve lung function in patients with acute asthma (<a href="./references#CD012629-bbs2-0038" title="RoweBH , SpoonerC , DucharmeF , BretzlaffJ , BotaG . Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database of Systematic Reviews2001, Issue 1. [DOI: 10.1002/14651858.CD002178] ">Rowe 2001</a>). A Cochrane Review reported significant decreases in symptom scores when patients were given systemic corticosteroids at or following discharge from the ED (i.e. an IM injection at discharge, or oral corticosteroids to be taken at home over the subsequent 3 to 8 days). Heterogeneity in outcome reporting prohibited meaningful pooling (<a href="./references#CD012629-bbs2-0039" title="RoweBH , SpoonerC , DucharmeF , BretzlaffJ , BotaG . Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD000195.pub2] ">Rowe 2007a</a>). Treatment with systemic corticosteroids at discharge has also been shown to prevent relapse (<a href="./references#CD012629-bbs2-0039" title="RoweBH , SpoonerC , DucharmeF , BretzlaffJ , BotaG . Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD000195.pub2] ">Rowe 2007a</a>). Current guidelines recommend systemic corticosteroids at ED discharge for all but the mildest presentations of acute asthma in an effort to reduce future relapse (<a href="./references#CD012629-bbs2-0029" title="Global Initiative forAsthma . Global Initative for Asthma. Global Strategy for Asthma Management and Prevention, 2017. ginasthma.org/2017‐gina‐report‐global‐strategy‐for‐asthma‐management‐and‐prevention/ (accessed 12 September 2016). ">GINA 2017</a>). While systemic corticosteroids can effectively mitigate asthma relapses, the optimal route of administration is less clear. </p> </section> <section id="CD012629-sec-0033"> <h3 class="title" id="CD012629-sec-0033">How the intervention might work</h3> <p>At discharge from the ED or acute care setting, systemic corticosteroids may be administered via intramuscular (IM) or oral routes. A single dose of IM corticosteroids has long‐acting pharmacokinetic properties with fewer side effects associated with nausea/vomiting; however, adverse events associated with the IM injection (i.e. pain and swelling around the injection site) are well known to occur (<a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>). Oral corticosteroids have short‐acting properties, and patients are typically provided with a short course of oral corticosteroids for five to seven days (<a href="./references#CD012629-bbs2-0029" title="Global Initiative forAsthma . Global Initative for Asthma. Global Strategy for Asthma Management and Prevention, 2017. ginasthma.org/2017‐gina‐report‐global‐strategy‐for‐asthma‐management‐and‐prevention/ (accessed 12 September 2016). ">GINA 2017</a>). While no injection is needed, side effects associated with oral corticosteroids often include nausea and vomiting, and adherence/compliance with oral corticosteroid regimens is often sub‐optimal (<a href="./references#CD012629-bbs2-0026" title="DucharmeFM , ZemekRL , ChalutD , McGillivrayD , NoyaFJ , ResendesS , et al. Written action plan in pediatric emergency room improves asthma prescribing, adherence, and control. American Journal of Respiratory and Critical Care Medicine2011;183(2):195‐203. [DOI: 10.1164/rccm.201001‐0115OC] ">Ducharme 2011</a>). Although IM corticosteroids represent an alternative treatment option for patients with intolerance to oral agents or patients where adherence/compliance concerns exist, it is unclear whether IM corticosteroids are as effective as oral corticosteroids in mitigating relapse. </p> </section> <section id="CD012629-sec-0034"> <h3 class="title" id="CD012629-sec-0034">Why it is important to do this review</h3> <p>The effectiveness of systemic corticosteroids is known (<a href="./references#CD012629-bbs2-0039" title="RoweBH , SpoonerC , DucharmeF , BretzlaffJ , BotaG . Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD000195.pub2] ">Rowe 2007a</a>), and widely accepted by clinicians; however, whether patients benefit more or less from IM or oral corticosteroids is less clear. This review provides supplemental information with another review of different oral corticosteroid regimens for acute asthma (<a href="./references#CD012629-bbs2-0034" title="NormansellR , KewKM , MansourG . Different oral corticosteroid regimens for acute asthma. Cochrane Database of Systematic Reviews2016, Issue 5. [DOI: 10.1002/14651858.CD011801.pub2] ">Normansell 2016</a>). An umbrella review reported no differences in relapse events in adults after treatment with IM or oral corticosteroids for acute asthma (<a href="./references#CD012629-bbs2-0032" title="KrishnanJA , DavisSQ , NaureckasET , GibsonP , RoweBH . An umbrella review: corticosteroid therapy for adults with acute asthma. American Journal of Medicine2009;122(11):977‐91. [DOI: 10.1016/j.amjmed.2009.02.013] ">Krishnan 2009</a>); however, this review was limited to English‐language studies, and since its publication no other systematic reviews have been conducted that have used an extensive literature search to synthesize all of the available evidence from studies that have compared IM to oral corticosteroids. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012629-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012629-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012629-sec-0133">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012629-sec-0035"></div> <p>To examine the effectiveness and safety of a single dose of intramuscular (IM) corticosteroids provided prior to discharge compared to a short course of oral corticosteroids in the treatment of acute asthma patients discharged from an ED or equivalent acute care setting. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012629-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012629-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012629-sec-0134">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012629-sec-0036"></div> <section id="CD012629-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012629-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCT) in this systematic review. We also included studies reported in full text, those published as an abstract only, and unpublished data in our search criteria. </p> </section> <section id="CD012629-sec-0039"> <h4 class="title">Types of participants</h4> <p>We considered for inclusion in the review studies that included children or adults presenting to a hospital ED or other equivalent acute care setting with an uncomplicated exacerbation of asthma. For the purposes of this review, we defined 'uncomplicated exacerbations' as patients whose acute exacerbation of asthma was the primary reason for presentation to the ED, with no coexisting complications (e.g. no evidence of pneumonia, pneumothorax, etc.). The asthma diagnosis had to be made either using international/national clinical guidelines, or spirometric criteria, or both. We excluded from this review studies that focused on corticosteroid treatment in hospitalised participants. We only included studies that assessed patients with acute asthma who were treated and discharged from the ED or other urgent care/acute care setting. None of the included studies enrolled participants with both chronic obstructive pulmonary disease (COPD) and asthma; however, we had determined a priori that if this were to be the case, we would only include these studies if they provided results of asthma participants separately from COPD participants, or if the study population of COPD participants consisted of less than 20% of the total population. </p> </section> <section id="CD012629-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included studies that compared a single dose of IM corticosteroids given prior to discharge versus a short course (one to 14 days) of oral corticosteroids. There were no restrictions on the IM or oral corticosteroids used, or the dosage. The single dose of IM corticosteroids may have been administered to participants at any point prior to discharge from the ED or other equivalent acute care setting. The short course of oral corticosteroids may have been started at any point prior to discharge or have been provided to participants to be taken over a period of a few days (one to 14 days) post‐discharge. We did not set any restrictions on the type of co‐interventions participants could receive (e.g. beta₂‐agonists, systemic or inhaled corticosteroids (ICS), anticholinergics, theophylline compounds, or antihistamines) during their stay in the ED/acute care setting; however, we did not permit other prescriptions of corticosteroids. </p> </section> <section id="CD012629-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD012629-sec-0042"> <h5 class="title">Primary outcomes</h5> <p>The primary dichotomous outcome was relapse to additional care defined as an unscheduled visit to a health practitioner for worsening asthma symptoms, or requiring subsequent treatment with corticosteroids, which may have occurred at any time point after discharge from the ED. We also accepted the occurrence of relapse at any point as well as whether the occurrence of relapse was reported via self‐report or verification via health records. </p> </section> <section id="CD012629-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD012629-list-0001"> <li> <p>The occurrence of serious adverse events (e.g. hospitalisation; intensive care unit (ICU) admission; death; relapse for visits other than worsening symptoms of asthma). </p> </li> <li> <p>Adverse events (e.g. pain, cellulitis/abscess, gastrointestinal bleeding, vomiting, behavioural/mental health exacerbations, abdominal pain, insomnia, hyperphagia/weight gain, skin eruptions, etc.). </p> </li> <li> <p>Continuous data from pulmonary function testing (including peak expiratory flow (PEF), absolute/per cent change in PEF from baseline; forced expiratory volume in one second (FEV₁), and absolute/per cent change in FEV₁ from baseline). </p> </li> <li> <p>Continuous data from symptom scores, measured via validated scales.</p> </li> <li> <p>Duration of symptoms (days until symptom free).</p> </li> <li> <p>Descriptive analysis of compliance/adherence with oral (corticosteroid or placebo) treatment. </p> </li> <li> <p>Quality of life measures measured via validated scale.</p> </li> <li> <p>The number of beta₂‐agonists doses taken by participants within a 24‐hour period of discharge. </p> </li> </ol> </p> <p>Reporting one or more of the outcomes listed here was not an inclusion criterion for the review. </p> </section> </section> </section> <section id="CD012629-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012629-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We identified studies from the Cochrane Airways Trials Register (CATR), which is maintained by the Information Specialist for the Cochrane Airways Group. The CATR contains studies identified from several sources. </p> <p> <ol id="CD012629-list-0002"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, through the Cochrane Register of Studies Online (<a href="http://crso.cochrane.org/" target="_blank">http://crso.cochrane.org/</a>). </p> </li> <li> <p>Weekly searches of MEDLINE Ovid SP.</p> </li> <li> <p>Weekly searches of Embase Ovid SP.</p> </li> <li> <p>Monthly searches of PsycINFO Ovid SP.</p> </li> <li> <p>Monthly searches of CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature).</p> </li> <li> <p>Monthly searches of AMED EBSCO (Allied and Complementary Medicine).</p> </li> <li> <p>Handsearches of the proceedings of major respiratory conferences.</p> </li> </ol> </p> <p>Studies contained in the CATR are identified through search strategies based on the scope of the Cochrane Airways Group. Details of these strategies, as well as a list of handsearched conference proceedings, are in <a href="./appendices#CD012629-sec-0103">Appendix 1</a>. See <a href="./appendices#CD012629-sec-0109">Appendix 2</a> for search terms used to identify studies for this review. This search was completed on 14 March 2018. </p> <p>In addition, an expert medical librarian (SC) conducted a supplemental search of nine electronic databases including MEDLINE (<a href="./appendices#CD012629-sec-0110">Appendix 3</a>), Embase (<a href="./appendices#CD012629-sec-0111">Appendix 4</a>), CINAHL (<a href="./appendices#CD012629-sec-0112">Appendix 5</a>), Proquest Dissertation Abstracts and Theses Global (<a href="./appendices#CD012629-sec-0113">Appendix 6</a>), SCOPUS (<a href="./appendices#CD012629-sec-0114">Appendix 7</a>), PROSPERO (<a href="./appendices#CD012629-sec-0115">Appendix 8</a>), the Cochrane Library (<a href="./appendices#CD012629-sec-0116">Appendix 9</a>), and LILACS (<a href="./appendices#CD012629-sec-0117">Appendix 10</a>) using controlled vocabulary and key words. </p> <p>We also conducted an extensive search of the grey literature including <a href="http://www.ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a>, the World Health Organization (WHO) International Clinical Trials Registry Platform (<a href="http://www.who.int/ictrp/en/" target="_blank">ICTRP</a>), Google Scholar, bibliographies of included studies and relevant reviews, and SCOPUS forward search of a sentinel paper; and a handsearch of medical conference abstracts from 2008 to 2017 including the Canadian Journal of Emergency Medicine, Academic Emergency Medicine, and Annals of Emergency Medicine. </p> <p>We conducted all searches without any restrictions on language or publication status.</p> </section> <section id="CD012629-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all primary studies and review articles for additional references. We also searched relevant manufacturers' web sites for study information. </p> <p>We searched for errata or retractions from included studies published in full text on <a href="http://www.ncbi.nlm.nih.gov/pubmed" target="_blank">PubMed</a> and planned to report the date this was done within the review. </p> </section> </section> <section id="CD012629-sec-0047"> <h3 class="title" id="CD012629-sec-0047">Data collection and analysis</h3> <section id="CD012629-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors (SWK and EC) screened the titles and abstracts of the search results independently and coded them as either potentially eligible or ineligible. We then retrieved the full‐text study reports of all potentially eligible studies and two review authors (SWK and EC) independently screened them for inclusion and recorded the reasons for exclusion of ineligible studies. We resolved any disagreement through discussion or, if required, we consulted a third review author (CVR or BHR). We identified and excluded duplicates and collated multiple reports of the same study so that each study, rather than each report, was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram and '<a href="./references#CD012629-sec-0126" title="">Characteristics of excluded studies</a>' table (<a href="./references#CD012629-bbs2-0033" title="MoherD , LiberatiA , TetzlaffJ , AltmanD . Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097] ">Moher 2009</a>). </p> </section> <section id="CD012629-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form for study characteristics and outcome data, which we piloted on at least one included study in the review. Two review authors (SWK and EC) independently extracted the following study characteristics from the included studies. </p> <p> <ol id="CD012629-list-0003"> <li> <p>Methods: study design, total duration of study, details of any 'run‐in' period, number of study centres and location, study setting, withdrawals, and date of study. </p> </li> <li> <p>Participants: number, mean age, age range, sex, severity of condition, diagnostic criteria, baseline lung function, smoking history, inclusion criteria, and exclusion criteria. </p> </li> <li> <p>Interventions: intervention, comparison, concomitant medications, and excluded medications.</p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, and time points reported. </p> </li> <li> <p>Notes: funding for studies and notable conflicts of interest of study authors.</p> </li> </ol> </p> <p>Two review authors (SWK and EC) independently extracted outcome data from included studies. We noted in the '<a href="./references#CD012629-sec-0125" title="">Characteristics of included studies</a>' table if an included study did not report outcome data in a usable way. We resolved disagreements by consensus or by involving a third review author (CVR or BHR). One review author (SWK) transferred data into the Review Manager 5 (RevMan 5) file (<a href="./references#CD012629-bbs2-0036" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). To ensure that the data was entered correctly, a second review author (EC) verified the extracted data for accuracy against the study report. </p> </section> <section id="CD012629-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (SWK and EC) assessed risk of bias independently for each included study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012629-bbs2-0031" title="HigginsJPT , GreenS . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We resolved any disagreements by discussion or by involving a third review author (CVR or BHR). We assessed the risk of bias according to the following domains. </p> <p> <ol id="CD012629-list-0004"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other bias.</p> </li> </ol> </p> <p>We judged each potential source of bias as high risk, low risk, or unclear risk and provided a quote from the study report together with a justification for our judgement in the 'Risk of bias' table. We summarised the 'Risk of bias' judgements across different studies for each of the domains listed. We considered blinding separately for different key outcomes where necessary. Where information on risk of bias relates to unpublished data or correspondence with an author, we noted this in the 'Risk of bias' table. </p> <p>When considering treatment effects, we took into account the risk of bias for the studies that may have contributed to that outcome. </p> <section id="CD012629-sec-0051"> <h5 class="title">Assessment of bias in conducting the systematic review</h5> <p>We conducted the review according to the published protocol and justify any deviations from it in the '<a href="#CD012629-sec-0123">Differences between protocol and review</a>' section of the systematic review. </p> </section> </section> <section id="CD012629-sec-0052"> <h4 class="title">Measures of treatment effect</h4> <p>Dichotomous data are reported as relative risk (RR) values and continuous data are reported as mean difference (MD) or standardised mean difference (SMD), as appropriate. If we combined data from rating scales in a meta‐analysis, we ensured we entered them with a consistent direction of effect (e.g. lower scores always indicate improvement). </p> <p>We undertook meta‐analyses only when meaningful; that is, if the treatments, participants, outcomes and the underlying interventions were similar enough for pooling to make sense. </p> <p>We provided a narrative description of skewed data reported as medians and interquartile ranges (IQR). </p> <p>In individual studies with multiple arms, we included only the study arms assessing IM and oral corticosteroids. If we combined two comparison groups (e.g. IM corticosteroids versus different regimens of oral corticosteroids) in the same meta‐analysis, we either combined the active study arms or halved the control group to avoid double‐counting. </p> <p>If a study reported outcomes at multiple time points, we used the last time point measured. </p> <p>We conducted an 'as reported' and intention‐to‐treat (ITT) analysis of the primary outcome. We assessed the secondary outcomes using an 'as reported' analysis. </p> </section> <section id="CD012629-sec-0053"> <h4 class="title">Unit of analysis issues</h4> <p>For dichotomous outcomes, we used participants, rather than events, as the unit of analysis (i.e. number of individuals who relapsed rather than number of relapses per individual). </p> </section> <section id="CD012629-sec-0054"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators or study sponsors in order to verify key study characteristics and obtain missing numerical outcome data where possible (e.g. if we identified a study as an abstract only). Where this was not possible and the missing data had the potential to introduce serious bias, we took this into consideration in the GRADE rating for affected outcomes. </p> </section> <section id="CD012629-sec-0055"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the I² statistic to measure heterogeneity among the studies in each analysis. If we identified substantial heterogeneity we reported it and explored the possible causes by prespecified subgroup analysis.  </p> </section> <section id="CD012629-sec-0056"> <h4 class="title">Assessment of reporting biases</h4> <p>We were unable to pool more than 10 studies, so we were unable to create a funnel plot to explore possible small study and publication biases. </p> </section> <section id="CD012629-sec-0057"> <h4 class="title">Data synthesis</h4> <p>We used a random‐effects model and performed a sensitivity analysis with a fixed‐effect model. </p> <section id="CD012629-sec-0058"> <h5 class="title">'Summary of findings' table</h5> <p>We created a 'Summary of findings' table using the following outcomes including: all relapse, relapse within 10 days post‐discharge, relapse after 10 days post‐discharge, adverse events, PEF/FEV₁, symptom scores, and beta₂‐agonist use in a 24‐hour period. We used the five GRADE considerations (i.e. risk of bias, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it related to the studies that contributed data for the prespecified outcomes. We used the methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012629-bbs2-0031" title="HigginsJPT , GreenS . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), and used GRADEpro software (<a href="./references#CD012629-bbs2-0030" title="McMaster University (developed by EvidencePrime). GRADEpro GDT. Version accessed 24 November 2016. Hamilton (ON): McMaster University (developed by EvidencePrime), 2015. ">GRADEpro GDT</a>). We justified all decisions to downgrade the quality of studies using footnotes and we made comments to aid the reader's understanding of the review where necessary. </p> </section> </section> <section id="CD012629-sec-0059"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We examined potential sources of heterogeneity in the primary outcome in the following subgroup analyses. </p> <p> <ol id="CD012629-list-0005"> <li> <p>Children (zero to 18 years of age) versus adults (18 years of age and older) to examine any potential age‐specific treatment effects of IM or oral corticosteroids. </p> </li> <li> <p>Relapse occurring within 10 days and over 10 days post‐discharge.</p> </li> <li> <p>Low versus moderate versus high exacerbation severity based on the pulmonary function taken at the time of the participant's presentation to the ED, prior to treatment with a bronchodilator. </p> </li> <li> <p>Co‐interventions received (ICS versus ICS corticosteroids/long‐acting beta₂‐agonists (LABA)). </p> </li> </ol> </p> <p>We used the formal test for subgroup interactions in RevMan 5 (<a href="./references#CD012629-bbs2-0036" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We restricted the subgroup analysis to relapse. </p> </section> <section id="CD012629-sec-0060"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out the following sensitivity analyses, by removing the following types of studies from the primary outcome analyses. </p> <p> <ol id="CD012629-list-0006"> <li> <p>Studies that we consider to be at high risk of bias based on the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012629-bbs2-0031" title="HigginsJPT , GreenS . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </li> <li> <p>Studies in which the duration of oral corticosteroid treatment was less than five days. </p> </li> <li> <p>The results from fixed‐effect models were compared with the random‐effects models for the main outcome. </p> </li> <li> <p>Studies in which supplemental corticosteroids were provided to the patients in the ED as a co‐intervention. </p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012629-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012629-sec-0061"></div> <section id="CD012629-sec-0062"> <h3 class="title">Description of studies</h3> <p>Please see <a href="./references#CD012629-sec-0125" title="">Characteristics of included studies</a> for additional information on the included studies. </p> <section id="CD012629-sec-0063"> <h4 class="title">Results of the search</h4> <p>The literature searches identified 912 studies (see <a href="#CD012629-fig-0001">Figure 1</a>). Removing duplicates resulted in 685 potentially eligible studies overall. We selected 20 studies for full‐text review, while we excluded the remaining 665 studies, based on lack of relevance. We excluded 11 studies after full‐text review (see <a href="#CD012629-sec-0071">Excluded studies</a>). We included the remaining nine studies in the review. We identified one of the eligible studies by grey literature search (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>). A search of errata or retractions in September 2017 did not identify any retracted publications. We included insufficient studies in this review for an assessment of publication bias (i.e. by a funnel plot). We made every effort to locate all available studies through an extensive search of the literature, with no limitations set on year of publication or language of publication. </p> <div class="figure" id="CD012629-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012629-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012629-sec-0064"> <h4 class="title">Included studies</h4> <section id="CD012629-sec-0065"> <h5 class="title">Publication</h5> <p>The first study to compare the effectiveness of IM versus oral corticosteroids in participants with acute asthma discharged from an acute care setting was published in 1988 (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>) while the most recent study was published in 2007 (<a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>). The majority of studies were published in the United States (<a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), while the remaining studies were published in Canada (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>), Jordan (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>), and Taiwan (<a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>). All of the studies were RCTs published in peer‐reviewed journals. </p> </section> <section id="CD012629-sec-0066"> <h5 class="title">Participants/Setting</h5> <p>The nine studies enrolled a total of 804 participants. Overall, the studies were small clinical trials, with a range of 17 to 187 participants across the studies. Five of the studies enrolled fewer than 90 participants each (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>). Five of the included studies enrolled adults (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), while the remaining four enrolled children (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). The age of eligible children included in the studies ranged from 9 months to 14 years (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>), 18 months to 7 years (<a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>), 6 months to 7 years (<a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>), and 3 to 16 years (<a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). Among the adult studies, the mean ages of participants ranged from 31 to 42 years old (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), while the mean age of children ranged from 3 to 6.8 years old (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). Most of the included studies recruited more male participants, except in three studies where women comprised over 50% of participants (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). Only three studies reported smoking history (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). <a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a> reported that current smokers made up 31% to 33% of the participants in the IM and oral corticosteroid groups respectively. Tobacco use ranged from 35% to 38% of participants randomised to the IM and oral corticosteroid groups respectively in <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>, while <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a> reported a range of 64% to 74% of participants randomised to receive IM or oral corticosteroids had ever smoked. All of the studies recruited participants with acute asthma presenting to an ED, except one study which recruited participants with acute asthma attending a primary care clinic (<a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>). We attempted to estimate and categorize exacerbation severity among the included studies based on the reported baseline pulmonary function of the included studies (<a href="#CD012629-tbl-0002">Table 1</a>). We considered studies that reported a baseline average PEF of greater than 200 L/min of the groups to be mild/moderate (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). We considered the exacerbation severity of patients enrolled in <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a> to be severe, as the baseline PEF of included patients was less than 150 L/min. Four studies did not report baseline pulmonary function and so exacerbation severity could not be estimated (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). </p> <div class="table" id="CD012629-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Exacerbation severity</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pulmonary function: Eligibility criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Exacerbation severity</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severity estimated using modified scoring system based on GINA guidelines. Reported to enrolling patients with mild‐moderate exacerbations, however baseline pulmonary function of the groups was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unable to assess</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported mean baseline PEF greater than 200 L/min: IM group: 270 L/min (SD: 103); oral group: 261 L/min (SD: 104). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mild/moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported to enrolling patients identified as moderate exacerbations, however baseline pulmonary function was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unable to assess</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Applied adapted exacerbation severity score (unspecified). Reported to enrolling patients rated as mild/moderate, however baseline pulmonary function of the groups was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unable to assess</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported baseline mean PEF of enrolled patients of less than 150 L/min: IM group: 129 L/min (SD:14); oral group: 141 L/min (SD: 14). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exacerbation severity estimated via pulmonary index score. Study reported to enrolling patients with mild/moderate exacerbations, however baseline pulmonary function was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unable to assess</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Eligibility criteria required patients to have a PEFR of ≤ 70% predicted with a minimum PEFR of ≥ 40%. Reported PEF of enrolled patients was ≥ 200 L/min: IM group: 205 L/min (SD: 70); oral group: 209 L/min (SD: 72). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mild/moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported mean baseline PEF of ≥ 200 L/min: IM group: 210 L/min (SD: 30); oral group: 208 L/min (SD: 26). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mild/moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported mean baseline PEF of ≥ 200 L/min: IM group: 243.6 L/min (SD: 64); oral group: 244.7 L/min (SD: 83). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mild/moderate</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations:</p> <p>GINA = Global Initiative for Asthma; PEF = Peak expiratory flow; PEFR = Peak expiratory flow rate; IM = intramuscular; SD = standard deviation </p> </div> </div> </section> <section id="CD012629-sec-0067"> <h5 class="title">Intervention</h5> <p>All of the paediatric studies provided their participants with a single dose of IM dexamethasone (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>), while the IM corticosteroid provided in adult studies ranged from methylprednisolone (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>), to betamethasone (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>), dexamethasone (<a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>), and triamcinolone (<a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). All of the participants randomised to receive IM corticosteroids received a single dose of IM corticosteroids prior to discharge. Only five studies were placebo controlled, in which all participants receiving IM corticosteroids were also provided with a course of oral placebo tablets (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). There was significant variation between the IM corticosteroid used, as well as the dosing. We provide additional information on the IM corticosteroids used in <a href="./references#CD012629-sec-0125" title="">Characteristics of included studies</a> and <a href="#CD012629-tbl-0003">Table 2</a>. We estimated corticosteroid equivalency to methylprednisolone using an equivalence converter (<a href="http://www.medcalc.com/steroid.html" target="_blank">www.medcalc.com/steroid.html</a>). Overall, the median dose was 78 mg with a range of 40 mg to 120 mg (<a href="#CD012629-tbl-0003">Table 2</a>). </p> <div class="table" id="CD012629-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Study characteristics of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Location/setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Co‐interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Corticosteroid doses and durations</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Methyprednisolone equivalency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relapse outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jordan, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: not stated</p> <p>Provided at discharge: SABA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexamethasone (IM)</b> </p> <p>1.7 mg/kg</p> <p>Mean dose: 24 mg</p> <p>Single dose</p> <p><b>Prednisolone (oral)</b> </p> <p>2 mg/kg/day for 5 days</p> <p>Mean dose: 19.2 mg per day</p> <p>Total dose: 96 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: 120 mg </p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>76.8 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>1/16</p> <p>Day 21</p> <p><b>Oral group</b> </p> <p>3/14</p> <p>Day 21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canada, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA, methylxanthines, supplemental oral/IV corticosteroids</p> <p>Provided at discharge: Methylxanthines, unspecified inhaled beta₂‐agonists, and ICS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Betamethasone (IM)</b> </p> <p>12 mg</p> <p>Single dose. Received placebo capsules over 7 days.</p> <p><b>Prednisone (oral)</b> </p> <p>50 mg a day for 7 days. Received a single placebo injection</p> <p>Total dose: 350 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>72 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>280 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>12/86</p> <p>Day 7</p> <p><b>Oral group</b> </p> <p>19/82</p> <p>Day 7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, Pediatric ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA, ipratropium bromide. IV corticosteroids for patients who vomited oral corticosteroids. </p> <p>Provided at discharge: Inhaled beta₂‐agonists and ICS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexamethasone (IM)</b> </p> <p>0.6 mg/kg (max 16 mg)</p> <p>Single dose</p> <p><b>Prednisolone (oral)</b> </p> <p>2 mg/kg (max 50 mg) daily for 5 days</p> <p>Total: 250 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>80 mg</p> <p>Duration: intermediate half‐life (12‐36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>200 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>8/69</p> <p>Day 4</p> <p><b>Oral group</b> </p> <p>11/73</p> <p>Day 4</p> <p><b>IM group</b> </p> <p>15/68</p> <p>Day 14</p> <p><b>Oral group</b> </p> <p>16/73</p> <p>Day 14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, Tertiary medical center</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA</p> <p>Provided at discharge: SABA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexamethasone (IM)</b> </p> <p>Patients 6 to 12 months old received 16 mg.</p> <p>Patients 13 to 35 months old received 24 mg.</p> <p>Children ≥ 36 months received 36 mg.</p> <p>Single dose</p> <p><b>Prednisone (oral)</b> </p> <p>2 mg/kg a day for 5 days</p> <p>Total dose: unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>Unable to assess</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>Unable to assess</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>1/15</p> <p>Day 28</p> <p><b>Oral group</b> </p> <p>3/17</p> <p>Day 28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA, epinephrine, methylxanthines, IV corticosteroids</p> <p>Provided at discharge: Methylxanthine and inhaled beta₂‐agonists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methylprednisonlone (IM)</b> </p> <p>80 mg</p> <p>Single dose. Received placebo capsules for 7 days</p> <p><b>Methylprednisolone (oral)</b> </p> <p>Tapering dose over 7 days.</p> <p>Total dose: 216 mg</p> <p>Received placebo injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>80 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>216 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>0/8 day</p> <p>Day 7</p> <p><b>Oral group</b> </p> <p>2/10</p> <p>Day 7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, Pediatric ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA</p> <p>Provided at discharge: SABA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexamethasone (IM)</b> </p> <p>0.3 mg/kg</p> <p>Total dose: 15 mg</p> <p>Single dose</p> <p><b>Prednisone (oral)</b> </p> <p>2 mg/kg a day for 3 days</p> <p>Total dose: 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>75 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>80 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>0/21</p> <p>Day 5</p> <p><b>Oral group</b> </p> <p>0/21</p> <p>Day 5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: inhaled beta₂‐agonists, IV corticosteroids</p> <p>Provided at discharge: SABA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methylprednisolone (IM)</b> </p> <p>160 mg</p> <p>Single dose. Received placebo capsules for 8 days</p> <p><b>Methylprednisolone (oral)</b> </p> <p>Tapering dose over 8 days.</p> <p>Total dose: 160 mg (tapering dose 32 mg day 1).</p> <p>Received placebo injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>80 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>80 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>13/92</p> <p>Day 10</p> <p><b>Oral group</b> </p> <p>12/88</p> <p>Day 10</p> <p><b>IM group</b> </p> <p>17/92</p> <p>Day 21</p> <p><b>Oral group</b> </p> <p>20/88</p> <p>Day 21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA, methylxanthines</p> <p>Provided at discharge: Methylxanthine and inhaled beta₂‐agonists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexamethasone (IM)</b> </p> <p>10 mg</p> <p>Single dose. Received placebo capsules for 7 days</p> <p><b>Dexamethasone (oral)</b> </p> <p>Tapering dose over 7 days.</p> <p>11.75 mg total. Received placebo injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>50 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>58.8 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>1/17</p> <p>Day 7</p> <p><b>Oral group</b> </p> <p>0/19</p> <p>Day 7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA, oral/IV corticosteroids</p> <p>Provided at discharge: SABA, antibiotics, ICS, cromolyn sodium, ipratropium bromide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Triamcinolone (IM)</b> </p> <p>40 mg</p> <p>Single dose. Received placebo capsules for 5 days</p> <p><b>Prednisone (oral)</b> </p> <p>40 mg a day for 5 days.</p> <p>Total dose: 160 mg</p> <p>Received placebo injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>40 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>160 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>7/78</p> <p>Day 7</p> <p><b>Oral group</b> </p> <p>11/76</p> <p>Day 7</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ED = emergency department; SABA = short‐acting beta₂‐agonists; LABA = long‐acting beta₂‐agonists; IV = intravenous; IM = intramuscular; ICS = inhaled corticosteroids </p> </div> </div> </section> <section id="CD012629-sec-0068"> <h5 class="title">Comparison</h5> <p>All of the paediatric studies compared IM dexamethasone to oral prednisone/prednisolone (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). The oral corticosteroid regimen provided in the adult studies consisted of either prednisone (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), methylprednisolone (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>), or dexamethasone (<a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>). The paediatric studies tended to provide participants a shorter course of oral corticosteroids, lasting from three (<a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>) to five days (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>). The course of oral corticosteroids tended to last slightly longer in the adult studies, ranging from five (<a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), seven (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>), to eight days (<a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>). Six studies provided a consistent dose of oral corticosteroids (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>) while three studies provided a tapering dose (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>). All participants randomised to receive oral corticosteroids were provided with their medications prior to discharge which was to be taken at home over the next 3 to 8 days. Only five studies were placebo controlled, in which all participants receiving oral corticosteroids were provided with IM placebo (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). We present additional information on the oral corticosteroids provided in <a href="./references#CD012629-sec-0125" title="">Characteristics of included studies</a> and <a href="#CD012629-tbl-0003">Table 2</a>. We estimated corticosteroid equivalency to methylprednisolone using an equivalence converter (<a href="http://www.medcalc.com/steroid.html" target="_blank">www.medcalc.com/steroid.html</a>). Overall, the median dose was 116 mg with a range of 58.8 mg to 280 mg (<a href="#CD012629-tbl-0003">Table 2</a>). </p> </section> <section id="CD012629-sec-0069"> <h5 class="title">Co‐interventions</h5> <p>The co‐interventions provided varied among the included studies (see <a href="./references#CD012629-sec-0125" title="">Characteristics of included studies</a> and <a href="#CD012629-tbl-0003">Table 2</a>). In some cases, all participants received standardised co‐interventions (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), while another study reported that participants received non‐standardized co‐interventions at the discretion of the attending physicians (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>). The most common co‐interventions provided to participants during the acute care visit included: SABA (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), methylxanthines (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>), and ipratropium bromide (<a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>). In some instances, some studies reported providing participants with supplemental oral (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>) or IV (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>) corticosteroids during their stay in the ED. <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a> provided participants with IV corticosteroids if they vomited the oral corticosteroids while in the ED. Co‐interventions provided to participants at discharge consisted primarily of SABA (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), methylxanthine (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>), LABA (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>), and unspecified inhaled beta₂‐agonists (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>). Supplemental corticosteroids provided at discharge were limited across the included studies. <a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a> and <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a> reported that the attending ED physician decided whether or not to provide participants with ICS at discharge. Participants in <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a> received ICS at discharge if they were using them previously. </p> </section> <section id="CD012629-sec-0070"> <h5 class="title">Outcomes</h5> <p>All included studies reported relapse to additional care, with a measurement range of four to 28 days after discharge. Seven studies assessed relapse within 10 days post‐discharge (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), while five studies measured relapse occurring more than 10 days post‐discharge (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>). Three studies assessed relapse at two different time points after discharge (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>). In comparison to relapse, we found infrequent reporting and inconsistent measurement of our proposed secondary outcomes. </p> </section> </section> <section id="CD012629-sec-0071"> <h4 class="title">Excluded studies</h4> <p>We excluded 11 studies from this review, mostly due to inappropriate study design (not an RCT) (<a href="./references#CD012629-bbs2-0010" title="AndrewsAL , WongKA , HeineD , ScottRW . A cost‐effectiveness analysis of dexamethasone versus prednisone in pediatric acute asthma exacerbations. Academic Emergency Medicine2012;19(8):943‐8. [DOI: 10.1111/j.1553‐2712.2012.01418.x] ">Andrews 2012</a>; <a href="./references#CD012629-bbs2-0020" title="DroszczW , LechB , PiotrowskaB , GarlickiA . Clinical evaluation of betamethasone depot. Pneumonologia Polska1981;49(8‐9):645‐8. [PUBMED: 7029485] ">Droszcz 1981</a>; <a href="./references#CD012629-bbs2-0011" title="DroszczW , PiotrowskaB . Comparison of oral prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma. Thorax1985;40(3):207‐8. [PUBMED: PMC460032] ">Droszcz 1985</a>; <a href="./references#CD012629-bbs2-0012" title="DucharmeFM , RoweBH . Intramuscular versus oral methylprednisolone in asthma. Lancet2004;364(9450):2000‐1. [DOI: 10.1016/S0140‐6736(04)17526‐0] ">Ducharme 2004</a>; <a href="./references#CD012629-bbs2-0013" title="GreenSS , LambGC , SchmittS , KaufmanJ . Oral versus repository corticosteroid therapy after hospitalization for the treatment of asthma. Journal of Allergy and Clinical Immunology1995;95(1):15‐22. [PUBMED: 7822659 ] ">Green 1995</a>; <a href="./references#CD012629-bbs2-0014" title="HofmannM , RodríguezJE , KlattC . What is the best treatment for an adult whose asthma exacerbation has not completely responded to 5 days of oral corticosteroids?. Evidence‐Based Practice2008;11(8):4. ">Hofmann 2008</a>; <a href="./references#CD012629-bbs2-0015" title="KelsoJM . Question 1: prednisolone or dexamethasone for acute exacerbations of asthma: do they have similar efficacy in the management of exacerbations of childhood asthma?. Pediatrics2014;134:S179. [DOI: 10.1542/peds.2014‐1817AAAA] ">Kelso 2014</a>; <a href="./references#CD012629-bbs2-0016" title="OzpenpeO , AydoganM , IraneciR . Comparison of the efficacy and side effects of intramuscular, intravenous and oral methylprednisolone used in the acute exacerbation of childhood asthma: A randomized clinical trial. Allergy2011;66(S94):668. [DOI: 10.1111/j.1398‐9995.2011.02650.x] ">Ozpenpe 2011</a>; <a href="./references#CD012629-bbs2-0017" title="RaziE , MoosaviGA . A comparative efficacy of oral prednisone with intramuscular triamcinolone in acute exacerbation of asthma. Iran Journal of Allergy, Asthma and Immunology2006;5(1):17‐22. [DOI: 05.01/ijaai.1722] ">Razi 2006</a>; <a href="./references#CD012629-bbs2-0018" title="WatnickCS , FabbriD , ArnoldDH . Single‐dose oral dexamethasone is effective in preventing relapse after acute asthma exacerbations. Annals of Allergy, Asthma &amp; Immunology2016;116(2):171‐2. [DOI: 10.1016/j.anai.2015.11.015] ">Watnick 2016</a>; <a href="./references#CD012629-bbs2-0019" title="WhiteS . BET 2 Dexamethasone versus prednisolone in asthma. Emergency Medicine Journal2010;27(9):716‐7. [DOI: 10.1136/emj.2010.101212] ">White 2010</a>) (See <a href="./references#CD012629-sec-0126" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD012629-sec-0072"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall, the risk of bias of the included studies ranged from unclear to high and none of the studies had an overall low risk of bias (see <a href="#CD012629-fig-0002">Figure 2</a>; <a href="#CD012629-fig-0003">Figure 3</a>). Of the nine studies assessed, we rated four as having high risk of bias (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>), while we assessed the remaining studies as having an unclear risk of bias (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). </p> <div class="figure" id="CD012629-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012629-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012629-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012629-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012629-sec-0073"> <h4 class="title">Allocation</h4> <p>Three studies provided adequate information on randomisation to allow for an assessment of low risk of bias for sequence generation (<a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). We considered the remaining studies to be at unclear risk of bias due to missing information on randomisation of participants (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). Five studies had a low risk of bias with regard to allocation concealment (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), while the remaining studies did not provide enough information to make a clear judgement on the risk of bias on allocation concealment (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>). </p> </section> <section id="CD012629-sec-0074"> <h4 class="title">Blinding</h4> <p>Given the feasibility of employing a placebo‐controlled study design, and that many outcomes of interest were collected via participant self‐report, we considered the primary and secondary outcomes of interest may have been susceptible to potential performance and detection bias. We considered three studies to have adequately blinded participants and personnel (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). Four studies did not blind participants or personnel, and we judged them to be at high risk of bias (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). We considered two studies to be at unclear risk of bias due to a lack of information provided (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>). Five studies reported adequate blinding of outcome assessors (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). We considered one study to be at high risk of bias because they did not blind outcome assessors (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>), while we considered three studies to be at unclear risk of bias due to a lack of available information on the blinding of outcome assessors (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>). </p> </section> <section id="CD012629-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed two studies as having an unclear risk of bias due to a lack of information on attrition (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>). We assessed the remaining studies as having a low risk of bias (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). </p> </section> <section id="CD012629-sec-0076"> <h4 class="title">Selective reporting</h4> <p>We considered only one study to be at low risk of bias for reporting bias; we received a study protocol upon request from the study authors (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>). We considered the remaining studies at be at unclear risk of reporting bias due to the lack of an available protocol (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). </p> </section> <section id="CD012629-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p>We considered four studies to be at low risk of bias for other potential sources of bias (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). Three studies reported their source of funding in the included article (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), while we found additional information regarding study funding in one study (<a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). Two studies received funding from general health research grants (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). One study received pharmaceutical company (Pfizer) sponsorship but reported that Pfizer was not involved in any aspect of the study or manuscript preparation (<a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>). One study was unfunded (<a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). We considered five studies to be at unclear risk of bias because the studies did not state their source of funding (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>). We did not consider any study to be at high risk of bias for other potential sources of bias. </p> </section> </section> <section id="CD012629-sec-0078"> <h3 class="title" id="CD012629-sec-0078">Effects of interventions</h3> <p>See: <a href="./full#CD012629-tbl-0001"><b>Summary of findings for the main comparison</b> Intramuscular corticosteroids compared to Oral corticosteroids for acute asthma</a> </p> <p>See <a href="./full#CD012629-tbl-0001">summary of findings Table for the main comparison</a> for a summary of the main comparisons. Insufficient reporting prevented meaningful meta‐analysis of several proposed secondary outcomes, including symptom scores; relapse requiring hospitalisation; and quality of life; and specific adverse events such as pain; swelling; redness/bruising; personality changes; and insomnia. </p> <section id="CD012629-sec-0079"> <h4 class="title">Primary Outcome</h4> <section id="CD012629-sec-0080"> <h5 class="title">Relapse</h5> <p>We detected no difference in the proportion of patients who relapsed between participants receiving IM versus oral corticosteroids (RR 0.94, 95% CI 0.72 to 1.24; 9 studies, 804 participants = 804; I² = 0%; <a href="./references#CD012629-fig-0004" title="">Analysis 1.1</a>) with low heterogeneity (I² = 0%). An ITT analysis revealed similar results (RR 0.95, 95% CI 0.72 to 1.26; 9 studies, 821 participants; I² = 0%; <a href="./references#CD012629-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD012629-sec-0081"> <h5 class="title">Subgroup analysis</h5> <p>A subgroup analysis comparing the effectiveness of IM versus oral corticosteroids to reduce relapse in paediatric (RR 0.86, 95% CI 0.48 to 1.53; 4 studies, 245 participants; I² = 0%) or adult (RR 0.97, 95% CI 0.71 to 1.33; 5 studies, 559 participants; I² = 0%) participants revealed no subgroup differences (P = 0.71; <a href="./references#CD012629-fig-0006" title="">Analysis 1.3</a>). In addition, we found no subgroup differences between studies assessing relapse within 10 days (RR 0.74, 95% CI 0.51 to 1.07; 7 studies, 742 participants; I² = 0%) or greater than 10 days post‐discharge (RR 0.99, 95% CI 0.74 to 1.33; 5 studies, 556 participants; I² = 0%) (P = 0.22; <a href="./references#CD012629-fig-0007" title="">Analysis 1.4</a>). It is important to note, however, that for the relapse greater than 10 days post‐discharge subgroup, it is unclear whether this includes relapses occurring within 10 days. We found no subgroup differences (P = 0.35; <a href="./references#CD012629-fig-0008" title="">Analysis 1.5</a>) in relapse between studies estimated to have enrolled participants with mild/moderate (RR 0.98, 95% CI 0.71 to 1.34; 4 studies, 539 participants; I² = 0%) versus severe exacerbations (RR 0.24, 95% CI 0.01 to 4.47; 1 study, 18 participants; I² = 100%). We could not complete the proposed co‐interventions subgroup comparing the effects of ICS versus ICS/LABA on relapse as planned due to a lack of studies providing information on the use of ICS and ICS/LABA agents as co‐interventions. </p> </section> <section id="CD012629-sec-0082"> <h5 class="title">Sensitivity analysis</h5> <p>We conducted a sensitivity analysis in which we removed from the meta‐analysis the four studies considered to be at high risk of bias (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). We identified no difference in relapse proportions between participants receiving IM or oral corticosteroids (RR 0.97, 95% CI 0.71 to 1.33; 5 studies, 559 participants; I² = 0%; <a href="./references#CD012629-fig-0009" title="">Analysis 1.6</a>). An additional sensitivity analysis, in which studies providing participants with an oral corticosteroid regimen of less than five days (<a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>), revealed no difference in relapse rates between participants receiving IM or oral corticosteroids (RR 0.94, 95% CI 0.72 to 1.24; 8 studies, 762 participants; I² = 0%; <a href="./references#CD012629-fig-0010" title="">Analysis 1.7</a>). Finally, fixed effects revealed similar findings to that of random effects (RR 0.91, 95% CI 0.69 to 1.19; 9 studies, 804 participants; I² = 0%; <a href="./references#CD012629-fig-0011" title="">Analysis 1.8</a>). Removing studies in which patients received additional corticosteroids as a co‐intervention during the patients' stay in the ED revealed no differences in relapse rates between participants receiving IM or oral corticosteroids (RR 0.76, 95% CI 0.45 to 1.29; 5 studies, 320 participants; I² = 0%; <a href="./references#CD012629-fig-0012" title="">Analysis 1.9</a>). </p> </section> </section> <section id="CD012629-sec-0083"> <h4 class="title">Secondary outcomes</h4> <section id="CD012629-sec-0084"> <h5 class="title">Serious adverse effects</h5> <p>Insufficient reporting of serious adverse events prohibited any meaningful meta‐analysis. Only one study reported on participants relapsing and requiring hospitalisation or ICU admission by 14‐day follow‐up; however, the effect estimate is imprecise (RR 1.43, 95% CI 0.33 to 6.16; 1 study, 141 participants; <a href="./references#CD012629-fig-0013" title="">Analysis 1.10</a>) (<a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>). </p> </section> <section id="CD012629-sec-0085"> <h5 class="title">Adverse events</h5> <p>Across the included studies we found poor documentation and inconsistent measurement of adverse events associated with the use of IM and oral corticosteroids, resulting in few meaningful comparisons. Overall, a meta‐analysis did not reveal whether participants receiving IM corticosteroids are more or less likely to experience any adverse events compared to participants receiving oral corticosteroids (RR 0.83, 95% CI 0.64 to 1.07; 5 studies, 404 participants; I² = 0%; <a href="./references#CD012629-fig-0014" title="">Analysis 1.11</a>). In some cases, the occurrence of specific adverse events was reported in greater detail. We found no differences in the frequency of nausea and vomiting among participants receiving either IM or oral corticosteroids (RR 0.56, 95% CI 0.09 to 3.59; 3 studies, 320 participants; I² = 58%; <a href="./references#CD012629-fig-0015" title="">Analysis 1.12</a>). We found insufficient evidence to conclusively state whether there is a difference in the occurrence of insomnia (RR 1.74, 95% CI 0.61 to 4.97; 1 study, 171 participants; I² = 0%; <a href="./references#CD012629-fig-0016" title="">Analysis 1.13</a>) or personality changes (RR 0.82, 95% CI 0.56 to 1.19; 1 study, 30 participants; I² = 0%; <a href="./references#CD012629-fig-0017" title="">Analysis 1.14</a>) among participants receiving IM or oral corticosteroids. Some studies reported the occurrence of side effects associated with the IM corticosteroid injection. Two studies strictly reported on the occurrence of pain, swelling, and redness at the injection site among participants receiving IM corticosteroids only, as these studies did not utilize a IM placebo control group (<a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>). <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a> reported the proportion of paediatric participants experiencing discomfort, swelling, and redness following the IM corticosteroid injection was 1.6%, 6.5%, and 1.6% respectively. <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a> reported that no paediatric participants receiving IM corticosteroids experienced any other side effects besides personality changes. Two placebo‐controlled studies compared the occurrence of pain, swelling, and redness between participants receiving IM corticosteroids compared to participants receiving oral corticosteroids who received an IM placebo injection. Overall, the imprecision of the estimate precluded identifying a difference in the occurrence of pain (RR 1.75, 95% CI 0.32 to 9.66; 2 studies, 181 participants; I² = 8%; <a href="./references#CD012629-fig-0018" title="">Analysis 1.15</a>), swelling (RR 4.76, 95% CI 0.57 to 39.84; 2 studies, 180 participants; I² = 0%; <a href="./references#CD012629-fig-0019" title="">Analysis 1.16</a>), or redness (RR 13.50, 95% CI 0.77 to 235.63; 2 studies, 175 participants; I² = 0%; <a href="./references#CD012629-fig-0020" title="">Analysis 1.17</a>) between participants receiving IM corticosteroids versus IM placebo. </p> </section> <section id="CD012629-sec-0086"> <h5 class="title">Pulmonary function</h5> <p>None of the included studies assessing a paediatric population collected PEF or FEV₁ measures. Four studies assessed PEF among an adult population following discharge from the ED. We found no differences in PEF between participants receiving IM versus oral corticosteroids at follow‐up (MD −7.78 L/min, 95% CI −38.83 L/min to 23.28 L/min; 4 studies, 272 participants; I² = 33%; <a href="./references#CD012629-fig-0021" title="">Analysis 1.18</a>). Only one study reported on FEV₁/FVC (%), and it reported no significant differences between participants receiving IM versus oral corticosteroids (MD −1.00, 95% CI −12.44 to 10.44; 1 study, 36 participants; I² = 0%; <a href="./references#CD012629-fig-0022" title="">Analysis 1.19</a>). No studies assessed per cent change in baseline PEF following discharge from the ED. </p> </section> <section id="CD012629-sec-0087"> <h5 class="title">Symptom scores</h5> <p>None of the included studies assessed symptom scores following discharge from the ED using validated scales. One study reported symptom scores for shortness of breath, cough, wheeze, activity limitation, and sleep disturbance at days 7 and 21 post‐discharge using an unspecified tool, in which participants were asked to give a score between 1 (indicating 'not present') to 10 (indicating 'most severe') for each symptom (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>). At day 21 post‐discharge, symptom scores between participants receiving IM versus oral corticosteroids were similar for each symptom including: shortness of breath (IM 3.8 (SD 2.4) n = 48; oral: 3.8 (SD 2.4) n = 58), cough (IM 2.8 (SD 2.2) n = 48; oral 3.4 (SD 2.4) n = 58), wheeze (IM 3.4 (SD 2.5) n = 48; oral 3.4 (SD 2.3) n = 58), activity limitation (IM 2.1 (SD 2.3) n = 48; oral 2.2 (SD 2.1) n = 58), and sleep disturbance (IM 2.9 (SD 2.7) n = 48; oral 2.8 (SD 2.7) n = 58). The study reported no significant differences in symptoms' scores between patients receiving IM or oral corticosteroids (P value not reported). </p> </section> <section id="CD012629-sec-0088"> <h5 class="title">Duration of symptoms</h5> <p>None of the included studies reported the duration for which symptoms occurred following discharge from the ED. Three studies reported whether participants were still experiencing non‐specific symptoms at the time of follow‐up, which was assessed at day 5 (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>) and between 5 to 7 days post‐discharge (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>). We found no significant differences in the presence of symptoms at follow‐up between participants receiving IM or oral corticosteroids (RR 0.41, 95% CI 0.14 to 1.20; 3 studies, 80 participants; I² = 44%; <a href="./references#CD012629-fig-0023" title="">Analysis 1.20</a>). Three studies reported whether participants were still experiencing cough (RR 0.69, 95% CI 0.17 to 2.73; 3 studies, 178 participants; I² = 50%; <a href="./references#CD012629-fig-0024" title="">Analysis 1.21</a>) or wheezing (RR 0.59, 95% CI 0.14 to 2.52; 3 studies, 177 participants; I² = 53%; <a href="./references#CD012629-fig-0025" title="">Analysis 1.22</a>) at the time of follow‐up but no differences between participants receiving IM versus oral corticosteroids were found. As previously noted, while <a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a> reported symptom scores for shortness of breath, cough, wheeze, activity limitation, and sleep disturbances at days 7 and 21 post‐discharge, the study did not assess whether there was a significant difference in symptom scores between the IM and oral corticosteroid groups at days 7 and 21. </p> </section> <section id="CD012629-sec-0089"> <h5 class="title">Compliance with oral medications</h5> <p>Three adult studies reported compliance with the oral corticosteroid treatment regimens. Although the overall compliance with the prescribed oral corticosteroid regimen varied, the reported adherence was high, with a low of 66.7% (n = 6/9; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>), to 94% (n = 64/68; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>), and 100% (n = 84/84; <a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>). Only two paediatric studies examined compliance with oral corticosteroids. <a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a> reported that eight parents reported difficulties in providing their children with the oral corticosteroid tablets and four children (n = 4/14) missed between 50% and 75% of their doses. <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a> reported that 41% (n = 7/17) of patients did not comply with their prescribed oral prednisone regimen, with three participants missing more than 75% of their oral prednisone doses, while another four children did not take one‐third of their medication. </p> </section> <section id="CD012629-sec-0090"> <h5 class="title">Beta agonist use</h5> <p>Two studies reported the use of beta₂‐agonists among participants 24 hours after discharge from the ED. We found no differences in beta₂‐agonists use 24 hours after discharge from the ED among participants receiving either IM or oral corticosteroids (RR 0.54, 95% CI 0.21 to 1.37; 2 studies, 48 participants; I² = 0%; <a href="./references#CD012629-fig-0026" title="">Analysis 1.23</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012629-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012629-sec-0091">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012629-sec-0159">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012629-sec-0091"></div> <section id="CD012629-sec-0092"> <h3 class="title" id="CD012629-sec-0092">Summary of main results</h3> <p>Systemic corticosteroids are an effective treatment in reducing relapses in patients with acute asthma after discharge from an emergency department (ED) or equivalent acute care setting (<a href="./references#CD012629-bbs2-0032" title="KrishnanJA , DavisSQ , NaureckasET , GibsonP , RoweBH . An umbrella review: corticosteroid therapy for adults with acute asthma. American Journal of Medicine2009;122(11):977‐91. [DOI: 10.1016/j.amjmed.2009.02.013] ">Krishnan 2009</a>; <a href="./references#CD012629-bbs2-0039" title="RoweBH , SpoonerC , DucharmeF , BretzlaffJ , BotaG . Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD000195.pub2] ">Rowe 2007a</a>). While systemic corticosteroids are commonly provided to prevent admission and reduce the risk of relapse, the optimal route of administration is unclear. </p> <p>This systematic review set out to compare the effectiveness of a single dose of intramuscular (IM) corticosteroids to a regimen of oral corticosteroids to prevent relapse among children and adult patients discharged from an ED or equivalent acute care setting for acute asthma. Utilizing methods to reduce publication and selection bias, we identified nine trials involving 804 participants comparing a single dose of IM to oral corticosteroids in adult and paediatric participants with acute asthma. </p> <p>Overall, this review could not identify a statistically significant difference in relapses among participants receiving IM versus oral corticosteroids. Furthermore, we identified no subgroup differences between children and adults, relapse occurring within or after 10 days post‐discharge, or participants presenting to the ED with a mild/moderate versus severe exacerbation. The effectiveness of IM versus oral corticosteroids to mitigate relapse remained consistent following several sensitivity analyses, including fixed versus random effects, variations in study quality, and variations in duration of oral corticosteroid regimens. Regarding other important clinical outcomes, the risk for adverse events among participants receiving IM corticosteroids ranged from a 36% decrease up to a 7% increase. Neither corticosteroid regimen demonstrated superiority with respect to pulmonary function measures, symptom persistence, or need for beta₂‐agonists following discharge. </p> <p>With a similar risk for relapse, the decision to provide patients with either IM or oral corticosteroids at discharge will likely involve other considerations such as patient preference, palatability, socio‐economic conditions, ability to afford prescriptions, side‐effect profile, and clinician estimation of patient adherence. This may vary between paediatric and adult patients. For patients who may have difficulties complying with an oral corticosteroid or patients who have previously experienced nausea or vomiting with oral corticosteroids, IM corticosteroids appear to provide physicians with an effective alternative. Unfortunately, a lack of reporting of many secondary outcomes of interest severely limited the number of studies that could be included in each meta‐analysis. While all of the included studies reported on relapse outcomes, the majority of secondary outcomes were reported sparingly across the included studies, and this limited the ability of this review to make any meaningful conclusions regarding the overall effectiveness of IM corticosteroids. </p> </section> <section id="CD012629-sec-0093"> <h3 class="title" id="CD012629-sec-0093">Overall completeness and applicability of evidence</h3> <p>We believe the overall completeness of the review to be moderate. We conducted an extensive search of the literature which identified nine studies including 804 participants. Among the nine studies, five enrolled adults (n = 559) (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>) while four studies involved children (n = 245) (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). </p> <p>Overall, the paediatric studies tended to focus on young children, with the mean ages of the IM and oral corticosteroid groups ranging from 3 to 7 years old. The age of eligible children included in the studies ranged from 9 months to 14 years (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>), 18 months to 7 years (<a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>), 6 months to 7 years (<a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>), and 3 to 16 years (<a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). It is important for future studies assessing the effectiveness of corticosteroids in children with acute asthma to attempt to ensure that the included patients had a true diagnosis of asthma: among the included children studies, only two of the studies reported only enrolling children with prior episodes of respiratory illness treated with bronchodilators (<a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). </p> <p>Within the paediatric studies, there is a paucity of studies on systemic corticosteroids in children aged 7 to 17 years old. Given the evidence that pre‐school‐aged children with acute asthma/wheezing may not respond to corticosteroids due to fewer airway eosinophils (<a href="./references#CD012629-bbs2-0022" title="Castro‐RodriguezJA , BeckhausAA , FornoE . Efficacy of oral corticosteroids in the treatment of acute wheezing episodes in asthmatic preschoolers: systematic review with meta‐analysis. Pediatric Pulmonology2016;51(8):868‐76. [DOI: 10.1002/ppul.23429] ">Castro‐Rodriguez 2016</a>), it is possible that the effectiveness of the IM or oral corticosteroid treatments may have been impacted by the age of the enrolled patients, which would affect the generalisability of this review. To our knowledge, efforts were made to avoid the inclusion of patients with a diagnosis of bronchiolitis in the included paediatric studies. This contamination, however, would have a conservative effect by decreasing the chance of detecting a difference. </p> <p>In the adult studies, the age of eligible participants ranged from over the age of 18 (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>), 15 to 55 (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>), 18 to 45 (<a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>), 16 to 60 (<a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>), and 18 to 50 years old (<a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). While the majority of studies included young and middle‐aged adults, only one study included patients over the age of 60 (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>). As a result, the results of this review may not be applicable to the teenage (up to age 14) and older (&gt; 60 years) patients with acute asthma. In addition, the effectiveness of corticosteroids in the paediatric studies may be underestimated due to the age of the participants included in the paediatric studies. All of the included studies enrolled patients presenting with acute asthma to the ED, except <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a> which enrolled patients in an paediatric medical clinic. Overall, the applicability of our review focuses primarily on very young (0 to 7 years old) and young/middle‐aged adults with acute asthma presenting to the ED with acute asthma in North America (United States/Canada). More research is needed in acute care centres across the world. In particular, additional paediatric (enrolling school aged children) or elderly studies are needed to better understand the effectiveness of IM versus oral corticosteroids in those patient populations. </p> <p>The type of IM agents used, as well as the doses employed, varied considerably across studies. For example, IM agents included methylprednisolone (<a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>), betamethasone (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>), dexamethasone (<a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>), and triamcinolone (<a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>); they also varied in dose. It is possible that the variation in the dosing and IM agents used could have impacted the effectiveness of this corticosteroid comparison. Moreover, the co‐interventions were poorly reported; and, given the age of some of the studies, the use of these agents in clinical practice likely has been stopped (e.g. metaproterenol, aminophylline, etc.). </p> <p>Some newer agents, which are now the mainstay of chronic asthma treatment such as ICS and ICS/LABA agents, were either not prescribed or not reported in sufficient detail among the included studies. A recent study found that patients receiving ICS/LABA at presentation to the ED were at the highest risk of relapse following discharge (<a href="./references#CD012629-bbs2-0042" title="RoweBH , Villa‐RoelC , MajumdarSR , Abu‐LabanRB , AaronSD , StiellIG , et al. Rates and correlates of relapse following ED discharge for acute asthma: a Canadian 20‐site prospective cohort study. Chest2015;147(1):140‐9. [DOI: 10.1378/chest.14‐0843] ">Rowe 2015</a>) and there is evidence that ICS agents, when added to oral (and presumably IM) systemic corticosteroids at discharge, may reduce relapse (<a href="./references#CD012629-bbs2-0037" title="RoweBH , TraversAH , HolroydBR , KellyKD , BotaGW . Nebulized ipratropium bromide in acute pediatric asthma: does it reduce hospital admissions among children presenting to the emergency department?. Annals of Emergency Medicine1999;34(1):75‐85. [PUBMED: 10381998] ">Rowe 1999</a>). Among patients presenting with acute asthma who are already receiving ICS agents, fewer relapses occurred when ICS/LABA was substituted for ICS agents in addition to oral (and presumably IM) systemic corticosteroids at discharge (<a href="./references#CD012629-bbs2-0040" title="RoweBH , WongE , BlitzS , DinerB , MackeyD , RossS , et al. Adding long‐acting beta‐agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Academic Emergency Medicine2007;14(10):833‐40. [DOI: 10.1197/j.aem.2007.06.020] ">Rowe 2007b</a>). A lack of reporting on the use of ICS and ICS/LABA agents limited the ability of this review to estimate the impact of these agents on the efficacy of IM or oral corticosteroids. </p> <p>This review did not attempt to control for corticosteroid equivalency of the varying corticosteroids regimens used across the studies. It is possible that the dose and pharmacokinetic properties of various prescribed corticosteroids could have impacted the effectiveness of the IM or oral corticosteroids. Other studies have compared the effectiveness of oral prednisone compared to oral dexamethasone (which has a longer half‐life) to improve outcomes in children with acute asthma (<a href="./references#CD012629-bbs2-0035" title="PaniaguaN , LopezR , MuñozN , TamesM , MojicaE , Arana‐ArriE , et al. Randomized trial of dexamethasone versus prednisone for children with acute asthma exacerbations. Journal of Pediatrics2017;191:190‐6.e1. [DOI: doi.org/10.1016/j.jpeds.2017.08.030] ">Paniagua 2017</a>; <a href="./references#CD012629-bbs2-0034" title="NormansellR , KewKM , MansourG . Different oral corticosteroid regimens for acute asthma. Cochrane Database of Systematic Reviews2016, Issue 5. [DOI: 10.1002/14651858.CD011801.pub2] ">Normansell 2016</a>). A recently published Cochrane Review reported insufficient evidence to identify whether lower or shorter doses of oral corticosteroids were any less effective than longer or higher doses and recommended additional large high‐quality clinical trials (<a href="./references#CD012629-bbs2-0034" title="NormansellR , KewKM , MansourG . Different oral corticosteroid regimens for acute asthma. Cochrane Database of Systematic Reviews2016, Issue 5. [DOI: 10.1002/14651858.CD011801.pub2] ">Normansell 2016</a>). Additional studies comparing the effectiveness of varying IM corticosteroids (e.g. IM dexamethasone versus IM methylprednisone) and the impact of dosing/pharmacokinetics are needed. </p> </section> <section id="CD012629-sec-0094"> <h3 class="title" id="CD012629-sec-0094">Quality of the evidence</h3> <p>The overall risk of bias of the included studies ranged from unclear to high, with no studies being assessed as having a low risk of bias. Four high risk of bias studies were not placebo controlled trials (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>; <a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a>; <a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a>; <a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a>). The remaining studies had an overall unclear risk of bias (<a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a>; <a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a>; <a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a>; <a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a>; <a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a>). The majority of studies did not adequately describe their method of randomisation and all but <a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a> had an unclear risk of bias for selective outcome reporting due to a lack of an available protocol. Using GRADE, the overall quality of the outcomes ranged from low to moderate. We reduced to low quality the primary outcomes of relapse as well as relapse after 10 days due to overall unclear to high risk of bias of the studies, and imprecision due to wide confidence intervals including both benefit, harm, and no effect. We assessed the quality of the subgroup analyses for relapse to be low due to the low number of available patients and wide confidence intervals. We judged the quality of the outcome adverse events to be low quality due to the overall unclear to high risk of bias of the included studies and imprecision due to few events. We considered both 'symptom persistence' and '24 hour beta₂‐agonists use' to be low quality due the overall unclear to high risk of bias of the included studies, as well as few events. We assessed the 'outcome of relapse within 10 days' as being of moderate quality due to the overall unclear to high risk of bias of the studies. We reduced 'peak expiratory flow' to moderate quality due to imprecision of the results. </p> </section> <section id="CD012629-sec-0095"> <h3 class="title" id="CD012629-sec-0095">Potential biases in the review process</h3> <p>While there is always a potential for screening and study selection bias, we took several steps to attenuate this risk. An expert health sciences librarian conducted a comprehensive search of the literature, including the CATR, a separate search of nine electronic databases, and a detailed search of the grey literature. Indeed, we identified one study from the grey literature (<a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a>). We placed no limits with regard to language, date of publication, or status of publication on any of the searches. We translated and screened all foreign language articles identified. If the information provided in the text did not allow for a clear inclusion/exclusion decision, we attempted to contact study authors to clarify the information provided in the text. Two review authors independently completed study selection, including both title and abstract screening and full‐text review. Despite our efforts, we recognize that some studies could have been missed. Unfortunately, due to an insufficient number of included studies, publication bias could not be assessed as planned (<a href="./references#CD012629-bbs2-0031" title="HigginsJPT , GreenS . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). As such, the risk of publication bias should be considered unclear. </p> </section> <section id="CD012629-sec-0096"> <h3 class="title" id="CD012629-sec-0096">Agreements and disagreements with other studies or reviews</h3> <p>Only two reviews have been published comparing the effectiveness of IM versus oral corticosteroids in patients presenting to an acute care centre with acute asthma (<a href="./references#CD012629-bbs2-0032" title="KrishnanJA , DavisSQ , NaureckasET , GibsonP , RoweBH . An umbrella review: corticosteroid therapy for adults with acute asthma. American Journal of Medicine2009;122(11):977‐91. [DOI: 10.1016/j.amjmed.2009.02.013] ">Krishnan 2009</a>; <a href="./references#CD012629-bbs2-0043" title="RoweBH , KirklandSW , VandermeerB , CampbellS , NewtonA , DucharmeFM , et al. Prioritizing systemic corticosteroid treatments to mitigate relapse in adults with acute asthma: A systematic review and network meta‐analysis. Academic Emergency Medicine2017;24(3):371‐81. [DOI: 10.1111/acem.13107] ">Rowe 2017</a>). The results of this review are similar to a previously published umbrella review which compared the effectiveness of IM versus oral corticosteroids in adults (<a href="./references#CD012629-bbs2-0032" title="KrishnanJA , DavisSQ , NaureckasET , GibsonP , RoweBH . An umbrella review: corticosteroid therapy for adults with acute asthma. American Journal of Medicine2009;122(11):977‐91. [DOI: 10.1016/j.amjmed.2009.02.013] ">Krishnan 2009</a>). The review identified five adult studies (all five of which were included in this review) and reported no significant difference in relapse rates in adult participants receiving IM versus oral corticosteroids for acute asthma after discharge from an ED. Unlike the current review, <a href="./references#CD012629-bbs2-0032" title="KrishnanJA , DavisSQ , NaureckasET , GibsonP , RoweBH . An umbrella review: corticosteroid therapy for adults with acute asthma. American Journal of Medicine2009;122(11):977‐91. [DOI: 10.1016/j.amjmed.2009.02.013] ">Krishnan 2009</a> did not include paediatric studies. In addition, a recently published review compared the effectiveness of various regimens of systemic corticosteroids to reduce relapse in adults with acute asthma (<a href="./references#CD012629-bbs2-0043" title="RoweBH , KirklandSW , VandermeerB , CampbellS , NewtonA , DucharmeFM , et al. Prioritizing systemic corticosteroid treatments to mitigate relapse in adults with acute asthma: A systematic review and network meta‐analysis. Academic Emergency Medicine2017;24(3):371‐81. [DOI: 10.1111/acem.13107] ">Rowe 2017</a>). Unlike the current review which strictly included studies comparing IM versus oral corticosteroids, <a href="./references#CD012629-bbs2-0043" title="RoweBH , KirklandSW , VandermeerB , CampbellS , NewtonA , DucharmeFM , et al. Prioritizing systemic corticosteroid treatments to mitigate relapse in adults with acute asthma: A systematic review and network meta‐analysis. Academic Emergency Medicine2017;24(3):371‐81. [DOI: 10.1111/acem.13107] ">Rowe 2017</a> included any studies comparing IM or oral corticosteroids to other oral corticosteroid or placebo regimens and conducted indirect comparisons using a Bayesian network analysis. The review reported that both IM and long‐course oral corticosteroids were effective in reducing relapse, with a risk of bias ability of best analysis identifying IM corticosteroids as having the highest risk of bias of being the most effective treatment option compared to short‐course or long‐course oral corticosteroids. Unlike the current review, <a href="./references#CD012629-bbs2-0043" title="RoweBH , KirklandSW , VandermeerB , CampbellS , NewtonA , DucharmeFM , et al. Prioritizing systemic corticosteroid treatments to mitigate relapse in adults with acute asthma: A systematic review and network meta‐analysis. Academic Emergency Medicine2017;24(3):371‐81. [DOI: 10.1111/acem.13107] ">Rowe 2017</a> did not exclusively compare the effectiveness of IM versus oral corticosteroids to mitigate relapse. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012629-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012629-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012629-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012629-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 1 Relapse." data-id="CD012629-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 1 Relapse.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 2 Relapse intention to treat." data-id="CD012629-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 2 Relapse intention to treat. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 3 Subgroup analysis: children versus adults." data-id="CD012629-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 3 Subgroup analysis: children versus adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 4 Subgroup analysis: relapse within 10 days and over 10 days post‐discharge." data-id="CD012629-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 4 Subgroup analysis: relapse within 10 days and over 10 days post‐discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 5 Subgroup analysis: mild/moderate versus severe exacerbations." data-id="CD012629-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 5 Subgroup analysis: mild/moderate versus severe exacerbations. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 6 Sensitivity analysis: risk of bias." data-id="CD012629-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 6 Sensitivity analysis: risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 7 Sensitivity analysis: oral corticosteroid prescriptions greater than 5 days." data-id="CD012629-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 7 Sensitivity analysis: oral corticosteroid prescriptions greater than 5 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 8 Sensitivity analysis: fixed effects." data-id="CD012629-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 8 Sensitivity analysis: fixed effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 9 Sensitivity analysis: corticosteroids in ED." data-id="CD012629-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 9 Sensitivity analysis: corticosteroids in ED. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 10 Serious adverse events; hospitalization following discharge." data-id="CD012629-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 10 Serious adverse events; hospitalization following discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 11 Adverse events." data-id="CD012629-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 11 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 12 Adverse events: nausea/vomiting/GI distress." data-id="CD012629-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 12 Adverse events: nausea/vomiting/GI distress. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 13 Adverse events: insomnia." data-id="CD012629-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 13 Adverse events: insomnia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 14 Adverse events: personality changes." data-id="CD012629-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 14 Adverse events: personality changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 15 Adverse events: pain." data-id="CD012629-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 15 Adverse events: pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 16 Adverse events: swelling." data-id="CD012629-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 16 Adverse events: swelling. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 17 Adverse events: redness." data-id="CD012629-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 17 Adverse events: redness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 18 Pulmonary function: peak expiratory flow (L/min)." data-id="CD012629-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 18 Pulmonary function: peak expiratory flow (L/min). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 19 Pulmonary function: FEV₁/FVC (%)." data-id="CD012629-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 19 Pulmonary function: FEV₁/FVC (%). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 20 Symptom persistence." data-id="CD012629-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 20 Symptom persistence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 21 Symptom persistence: cough." data-id="CD012629-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 21 Symptom persistence: cough. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 22 Symptom persistence: wheezing." data-id="CD012629-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 22 Symptom persistence: wheezing. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012629-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/urn:x-wiley:14651858:media:CD012629:CD012629-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_t/tCD012629-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intramuscular versus oral corticosteroids, Outcome 23 24‐hour beta agonist use." data-id="CD012629-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Intramuscular versus oral corticosteroids, Outcome 23 24‐hour beta agonist use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/media/CDSR/CD012629/image_n/nCD012629-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012629-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Intramuscular corticosteroids compared to Oral corticosteroids for acute asthma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Intramuscular corticosteroids compared to Oral corticosteroids for acute asthma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with acute asthma<br/> <b>Settings:</b> Acute care settings<br/> <b>Intervention:</b> Intramuscular corticosteroids<br/> <b>Comparison:</b> Oral corticosteroids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Oral corticosteroids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Intramuscular corticosteroids</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relapse</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>201 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>12 fewer per 1000</b><br/> (from 56 fewer to 48 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b> <br/> (0.72 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>804<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relapse within 10 days post</b> ‐<b>discharge</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>154 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>40 fewer per 1000</b> </p> <p>(from 75 fewer to 11 more)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.74</b> <br/> (0.51 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>742<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relapse occurring after 10 days post</b> ‐<b>discharge</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>245 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>2 fewer per 1000</b><br/> (from 64 fewer to 81 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.99</b> <br/> (0.74 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>556<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>294 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>50 fewer per 1000</b><br/> (from 106 fewer to 21 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b> <br/> (0.64 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>404<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pulmonary function: Peak expiratory flow</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pulmonary function: peak expiratory flow ranged across control groups from<br/> <b>304 to 419 litres/min</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pulmonary function: peak expiratory flow in the intervention groups was<br/> <b>7.78 liters/min lower</b><br/> (38.83 lower to 23.28 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>272<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptom persistence</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>537 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>317 fewer per 1000</b><br/> (from 461 fewer to 107 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.41</b> <br/> (0.14 to 1.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>24</b> ‐<b>hour beta agonist use</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>375 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>172 fewer per 1000</b><br/> (from 296 fewer to 139 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.54</b> <br/> (0.21 to 1.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded 1 level for risk of bias. Majority of studies received an unclear risk of bias for random sequence generation and selective outcome reporting<br/> <sup>2</sup> Downgraded 1 level for imprecision including wide confidence intervals (including both benefit, harm, and no effect)<br/> <sup>3</sup> Downgraded 1 level for Imprecision including wide confidence intervals (including both benefit, harm, and no effect) and few events </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Intramuscular corticosteroids compared to Oral corticosteroids for acute asthma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012629-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Exacerbation severity</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pulmonary function: Eligibility criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Exacerbation severity</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severity estimated using modified scoring system based on GINA guidelines. Reported to enrolling patients with mild‐moderate exacerbations, however baseline pulmonary function of the groups was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unable to assess</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported mean baseline PEF greater than 200 L/min: IM group: 270 L/min (SD: 103); oral group: 261 L/min (SD: 104). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mild/moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported to enrolling patients identified as moderate exacerbations, however baseline pulmonary function was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unable to assess</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Applied adapted exacerbation severity score (unspecified). Reported to enrolling patients rated as mild/moderate, however baseline pulmonary function of the groups was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unable to assess</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported baseline mean PEF of enrolled patients of less than 150 L/min: IM group: 129 L/min (SD:14); oral group: 141 L/min (SD: 14). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exacerbation severity estimated via pulmonary index score. Study reported to enrolling patients with mild/moderate exacerbations, however baseline pulmonary function was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unable to assess</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Eligibility criteria required patients to have a PEFR of ≤ 70% predicted with a minimum PEFR of ≥ 40%. Reported PEF of enrolled patients was ≥ 200 L/min: IM group: 205 L/min (SD: 70); oral group: 209 L/min (SD: 72). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mild/moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported mean baseline PEF of ≥ 200 L/min: IM group: 210 L/min (SD: 30); oral group: 208 L/min (SD: 26). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mild/moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported mean baseline PEF of ≥ 200 L/min: IM group: 243.6 L/min (SD: 64); oral group: 244.7 L/min (SD: 83). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mild/moderate</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>Abbreviations:</p> <p>GINA = Global Initiative for Asthma; PEF = Peak expiratory flow; PEFR = Peak expiratory flow rate; IM = intramuscular; SD = standard deviation </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Exacerbation severity</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012629-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Study characteristics of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Location/setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Co‐interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Corticosteroid doses and durations</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Methyprednisolone equivalency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relapse outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0001" title="Al‐WahadnehA , JboorS , DahabrehM . A comparison of efficacy and safety of a single dose of intramuscular dexamethasone acetate with oral prednisolone in the management of asthma exacerbations in children. Journal of the Royal Medical Services2006;13(1):15‐8. ">Al‐Wahadneh 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jordan, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: not stated</p> <p>Provided at discharge: SABA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexamethasone (IM)</b> </p> <p>1.7 mg/kg</p> <p>Mean dose: 24 mg</p> <p>Single dose</p> <p><b>Prednisolone (oral)</b> </p> <p>2 mg/kg/day for 5 days</p> <p>Mean dose: 19.2 mg per day</p> <p>Total dose: 96 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: 120 mg </p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>76.8 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>1/16</p> <p>Day 21</p> <p><b>Oral group</b> </p> <p>3/14</p> <p>Day 21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0002" title="ChanJS , CowieRL , LazarenkoGC , LittleC , ScottS , FordGT . Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Canadian Respiratory Journal2001;8(3):147‐52. [PUBMED: 11420590] ">Chan 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canada, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA, methylxanthines, supplemental oral/IV corticosteroids</p> <p>Provided at discharge: Methylxanthines, unspecified inhaled beta₂‐agonists, and ICS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Betamethasone (IM)</b> </p> <p>12 mg</p> <p>Single dose. Received placebo capsules over 7 days.</p> <p><b>Prednisone (oral)</b> </p> <p>50 mg a day for 7 days. Received a single placebo injection</p> <p>Total dose: 350 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>72 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>280 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>12/86</p> <p>Day 7</p> <p><b>Oral group</b> </p> <p>19/82</p> <p>Day 7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0003" title="GordonS , TompkinsT , DayanPS . Randomized trial of single‐dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatric Emergency Care2007;23(8):521‐7. [DOI: 10.1097/PEC.0b013e318128f821] ">Gordon 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, Pediatric ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA, ipratropium bromide. IV corticosteroids for patients who vomited oral corticosteroids. </p> <p>Provided at discharge: Inhaled beta₂‐agonists and ICS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexamethasone (IM)</b> </p> <p>0.6 mg/kg (max 16 mg)</p> <p>Single dose</p> <p><b>Prednisolone (oral)</b> </p> <p>2 mg/kg (max 50 mg) daily for 5 days</p> <p>Total: 250 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>80 mg</p> <p>Duration: intermediate half‐life (12‐36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>200 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>8/69</p> <p>Day 4</p> <p><b>Oral group</b> </p> <p>11/73</p> <p>Day 4</p> <p><b>IM group</b> </p> <p>15/68</p> <p>Day 14</p> <p><b>Oral group</b> </p> <p>16/73</p> <p>Day 14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0004" title="GriesDM , MoffittDR , PulosE , CarterER . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. Journal of Pediatrics2000;136(3):298‐303. [DOI: 10.1067/mpd.2000.103353] ">Gries 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, Tertiary medical center</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA</p> <p>Provided at discharge: SABA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexamethasone (IM)</b> </p> <p>Patients 6 to 12 months old received 16 mg.</p> <p>Patients 13 to 35 months old received 24 mg.</p> <p>Children ≥ 36 months received 36 mg.</p> <p>Single dose</p> <p><b>Prednisone (oral)</b> </p> <p>2 mg/kg a day for 5 days</p> <p>Total dose: unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>Unable to assess</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>Unable to assess</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>1/15</p> <p>Day 28</p> <p><b>Oral group</b> </p> <p>3/17</p> <p>Day 28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0005" title="HoffmanIB , FielSB . Oral versus repository corticosteroid therapy in acute asthma. Chest1988;93(1):11‐3. [PUBMED: 3275525] ">Hoffman 1988</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA, epinephrine, methylxanthines, IV corticosteroids</p> <p>Provided at discharge: Methylxanthine and inhaled beta₂‐agonists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methylprednisonlone (IM)</b> </p> <p>80 mg</p> <p>Single dose. Received placebo capsules for 7 days</p> <p><b>Methylprednisolone (oral)</b> </p> <p>Tapering dose over 7 days.</p> <p>Total dose: 216 mg</p> <p>Received placebo injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>80 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>216 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>0/8 day</p> <p>Day 7</p> <p><b>Oral group</b> </p> <p>2/10</p> <p>Day 7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0006" title="KligJE , HodgeD , RutherfordMW . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. Journal of Asthma1997;34(5):419‐25. [PUBMED: 9350159] ">Klig 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, Pediatric ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA</p> <p>Provided at discharge: SABA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexamethasone (IM)</b> </p> <p>0.3 mg/kg</p> <p>Total dose: 15 mg</p> <p>Single dose</p> <p><b>Prednisone (oral)</b> </p> <p>2 mg/kg a day for 3 days</p> <p>Total dose: 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>75 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>80 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>0/21</p> <p>Day 5</p> <p><b>Oral group</b> </p> <p>0/21</p> <p>Day 5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0007" title="LahnM , BijurP , GallagherEJ . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest2004;126(2):362‐8. [DOI: 10.1378/chest.126.2.362] ">Lahn 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: inhaled beta₂‐agonists, IV corticosteroids</p> <p>Provided at discharge: SABA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methylprednisolone (IM)</b> </p> <p>160 mg</p> <p>Single dose. Received placebo capsules for 8 days</p> <p><b>Methylprednisolone (oral)</b> </p> <p>Tapering dose over 8 days.</p> <p>Total dose: 160 mg (tapering dose 32 mg day 1).</p> <p>Received placebo injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>80 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>80 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>13/92</p> <p>Day 10</p> <p><b>Oral group</b> </p> <p>12/88</p> <p>Day 10</p> <p><b>IM group</b> </p> <p>17/92</p> <p>Day 21</p> <p><b>Oral group</b> </p> <p>20/88</p> <p>Day 21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0008" title="LeeCH , LeeCJ , LanRS , TsaiYH , ChiangYC , WangWJ , et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi [Chang Gung Medical Journal]1993;16(1):25‐9. [PUBMED: 8490772] ">Lee 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA, methylxanthines</p> <p>Provided at discharge: Methylxanthine and inhaled beta₂‐agonists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexamethasone (IM)</b> </p> <p>10 mg</p> <p>Single dose. Received placebo capsules for 7 days</p> <p><b>Dexamethasone (oral)</b> </p> <p>Tapering dose over 7 days.</p> <p>11.75 mg total. Received placebo injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>50 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>58.8 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>1/17</p> <p>Day 7</p> <p><b>Oral group</b> </p> <p>0/19</p> <p>Day 7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012629-bbs2-0009" title="SchuckmanH , DeJuliusDP , BlandaM , GersonLW , DeJuliusAJ , RajaratnamM . Comparison of intramuscular triamcinolone and oral prednisone in the out‐patient treatment of acute asthma: a randomized controlled trial. Annals of Emergency Medicine1998;31(3):333‐8. [PUBMED: 9506490] ">Schuckman 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>United States, ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Provided in ED: SABA, oral/IV corticosteroids</p> <p>Provided at discharge: SABA, antibiotics, ICS, cromolyn sodium, ipratropium bromide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Triamcinolone (IM)</b> </p> <p>40 mg</p> <p>Single dose. Received placebo capsules for 5 days</p> <p><b>Prednisone (oral)</b> </p> <p>40 mg a day for 5 days.</p> <p>Total dose: 160 mg</p> <p>Received placebo injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM</b> </p> <p><b>Methylprednisone equivalency</b>: </p> <p>40 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> <p><b>Oral</b> </p> <p><b>Methylprednisone equivalency:</b> </p> <p>160 mg</p> <p>Duration: intermediate half‐life (12 to 36 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IM group</b> </p> <p>7/78</p> <p>Day 7</p> <p><b>Oral group</b> </p> <p>11/76</p> <p>Day 7</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>ED = emergency department; SABA = short‐acting beta₂‐agonists; LABA = long‐acting beta₂‐agonists; IV = intravenous; IM = intramuscular; ICS = inhaled corticosteroids </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Study characteristics of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/full#CD012629-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012629-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Intramuscular versus oral corticosteroids</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>804</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.72, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Relapse intention to treat <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>821</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.72, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Subgroup analysis: children versus adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>804</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.72, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.48, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.71, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Subgroup analysis: relapse within 10 days and over 10 days post‐discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Within 10 days post‐discharge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>742</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.51, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Greater than 10 days post‐discharge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>556</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.74, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Subgroup analysis: mild/moderate versus severe exacerbations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>557</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.70, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Mild/moderate exacerbations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.71, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Severe exacerbations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.01, 4.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Sensitivity analysis: risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.71, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Sensitivity analysis: oral corticosteroid prescriptions greater than 5 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>762</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.72, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Sensitivity analysis: fixed effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>804</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.69, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Sensitivity analysis: corticosteroids in ED <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.45, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Serious adverse events; hospitalization following discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.64, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Adverse events: nausea/vomiting/GI distress <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.09, 3.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Adverse events: insomnia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Adverse events: personality changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Adverse events: pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.32, 9.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Adverse events: swelling <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.76 [0.57, 39.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Adverse events: redness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.5 [0.77, 235.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Pulmonary function: peak expiratory flow (L/min) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.78 [‐38.83, 23.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Pulmonary function: FEV₁/FVC (%) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Symptom persistence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.14, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Symptom persistence: cough <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.17, 2.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Symptom persistence: wheezing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.14, 2.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 24‐hour beta agonist use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.21, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Intramuscular versus oral corticosteroids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012629.pub2/references#CD012629-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012629.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012629-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012629-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012629-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012629-note-0006">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012629-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD012629-note-0004">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012629-note-0002">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012629-note-0003">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012629\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012629\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012629\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012629\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012629\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=JmNqPX1V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012629.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012629.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012629.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012629.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012629.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716103156"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012629.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716103160"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012629.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d9752db9ff409',t:'MTc0MDcxNjEwMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 